Thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione Derivative thieno[2,3-d]pyrimidine-2,4(1h,3h)-dione T Th Thi Thie BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 0 [,-]-,(,)- 10 10 1 0 0 0 1
D-Dopachrome Tautomerase d-dopachrome D D- D-D D-Do BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 - 1 8 1 0 0 0 1
Proliferation of proliferation P Pr Pro Prol BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 - 1 8 1 0 0 0 1
Zhangping Xiao, zhangping Z Zh Zha Zhan BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 ,,,,.,, 7 10 1 0 0 0 1
Petra E. petra P Pe Pet Petr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 0 0 .,.,.,.,., 10 9 1 0 0 0 1
and Frank and a an and and BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 .* 2 2 1 0 0 0 1
Cite This: cite C Ci Cit Cite BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 1 :...,,- 7 10 1 0 0 0 1
Read Online read R Re Rea Read BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 0 1 no 0 2 1 0 0 0 1
ACCESS ACCESS access A AC ACC ACCE BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 0 1 no 0 10 1 0 0 0 1
Metrics & metrics M Me Met Metr BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 0 1 no 0 6 1 0 0 0 1
Article Recommendations article A Ar Art Arti BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 1 no 0 10 1 0 0 0 1
* sı * * * * * BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 0 1 * 1 10 1 0 0 0 1
ABSTRACT: The abstract: A AB ABS ABST BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 0 1 : 1 4 0 0 0 0 1
inhibitory factor inhibitory i in inh inhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 1 ()-(- 5 4 0 0 0 0 1
MIF2) play mif2) M MI MIF MIF2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 1 ). 2 4 0 0 0 0 1
tautomerase active tautomerase t ta tau taut BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 1 . 1 5 0 0 0 0 1
contrast, the contrast, c co con cont BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 , 1 5 0 0 0 0 1
of MIF2 of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 ., 2 4 0 0 0 0 1
compound collection compound c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 no 0 4 0 0 0 0 1
tautomerase inhibitor tautomerase t ta tau taut BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 1 . 1 4 0 0 0 0 1
inhibitor 5d inhibitor i in inh inhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 1 . 1 5 0 0 0 0 1
and a and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 . 1 5 0 0 0 0 1
non-small cell non-small n no non non- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 1 --()- 5 5 0 0 0 0 1
dimensional (3D) dimensional d di dim dime BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 (), 3 4 0 0 0 0 1
induction of induction i in ind indu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 -()., 5 9 0 0 0 0 1
characterized MIF2 characterized c ch cha char BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 (), 3 10 0 0 0 0 1
of targeting of o of of of BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 . 1 2 0 0 0 0 1
■ INTRODUCTION ■ ■ ■ ■ ■ BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 0 4 no 0 10 1 0 0 0 1
Cancer is cancer C Ca Can Canc BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 4 no 0 8 1 0 0 0 1
contributes to contributes c co con cont BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 no 0 9 1 0 0 0 1
million worldwide. million m mi mil mill BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 . 1 9 1 0 0 0 1
achieved enormous achieved a ac ach achi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 , 1 8 1 0 0 0 1
effectiveness is effectiveness e ef eff effe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 no 0 8 1 0 0 0 1
therapy resistance therapy t th the ther BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 ., 2 9 1 0 0 0 1
explore novel explore e ex exp expl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 no 0 8 1 0 0 0 1
therapeutic agents therapeutic t th the ther BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 . 1 8 1 0 0 0 1
possibilities to possibilities p po pos poss BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 no 0 9 1 0 0 0 1
also increase also a al als also BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 no 0 9 1 0 0 0 1
regimens. 3 regimens. r re reg regi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 4 .() 3 9 1 0 0 0 1
family proteins family f fa fam fami BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 , 1 9 1 0 0 0 1
which is which w wh whi whic BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 no 0 8 1 0 0 0 1
proteins in proteins p pr pro prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 ,, 2 10 1 0 0 0 1
melanoma, 5 melanoma, m me mel mela BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 4 ,,., 4 9 1 0 0 0 1
downregulation of downregulation d do dow down BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 4 - 1 9 1 0 0 0 1
gene-knockdown 9,10 gene-knockdown g ge gen gene BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 4 -, 2 9 1 0 0 0 1
and induction and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 ., 2 8 1 0 0 0 1
family proteins family f fa fam fami BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 no 0 8 1 0 0 0 1
therapeutics. therapeutics. therapeutics. t th the ther BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 4 . 1 2 1 0 0 0 1
The most the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 4 no 0 8 1 0 0 0 1
macrophage migration macrophage m ma mac macr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 4 (), 3 8 1 0 0 0 1
initially discovered initially i in ini init BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 ., 2 9 1 0 0 0 1
there is there t th the ther BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 no 0 8 1 0 0 0 1
proliferation of proliferation p pr pro prol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 . 1 10 1 0 0 0 1
through various through t th thr thro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 ,, 2 8 1 0 0 0 1
cognate receptor cognate c co cog cogn BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 7 ()., 4 9 1 0 0 0 1
CD74 binding cd74 C CD CD7 CD74 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 7 , 1 8 1 0 0 0 1
which stabilizes which w wh whi whic BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 no 0 9 1 0 0 0 1
progression to progression p pr pro prog BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 ., 2 8 1 0 0 0 1
activation of activation a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 , 1 9 1 0 0 0 1
which results which w wh whi whic BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 . 1 10 1 0 0 0 1
partners of partners p pa par part BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 , 1 9 1 0 0 0 1
roles in roles r ro rol role BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 .- 2 9 1 0 0 0 1
substantial potency substantial s su sub subs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 - 1 8 1 0 0 0 1
signaling pathway signaling s si sig sign BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 7 - 1 9 1 0 0 0 1
ation. 14,15 ation. a at ati atio BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 7 ., 2 1 1 0 0 0 1
D-Dopachrome tautomerase d-dopachrome D D- D-D D-Do BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 7 -(-) 4 8 1 0 0 0 1
and functional and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 . 1 8 1 0 0 0 1
studies on studies s st stu stud BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 , 1 8 1 0 0 0 1
Received: September received: R Re Rec Rece BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 10 :, 2 10 1 0 0 0 1
Published: January published: P Pu Pub Publ BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 10 :, 2 9 1 0 0 0 1
Article Article article A Ar Art Arti BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 10 no 0 4 1 1 0 0 1
pubs.acs.org/jmc pubs.acs.org/jmc pubs.acs.org/jmc p pu pub pubs BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 10 ../ 3 10 1 1 0 0 1
© 2022 © © © © © BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 0 10 . 1 10 1 1 0 0 0
American Chemical american A Am Ame Amer BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 10 no 0 7 1 1 0 0 0
2059 2059 2059 2 20 205 2059 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 0 11 no 0 10 1 1 0 0 0
https://doi.org/10.1021/acs.jmedchem.1c01598 https://doi.org/10.1021/acs.jmedchem.1c01598 https://doi.org/10.1021/acs.jmedchem.1c01598 h ht htt http BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 0 11 ://././.. 9 10 1 1 0 0 0
J. Med. j. J J. J. J. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 11 ...,,- 6 7 1 1 0 0 0
Downloaded via downloaded D Do Dow Down BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 11 ...,::(). 9 10 0 0 0 0 0
See https://pubs.acs.org/sharingguidelines see S Se See See BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 0 11 ://../. 7 10 0 0 0 0 0
relatively recently relatively r re rel rela BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 . 1 9 1 1 0 0 1
and MIF and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 . 1 9 1 1 0 0 1
structure shows structure s st str stru BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 9 1 1 0 0 1
of MIF2 of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ,-- 3 9 1 1 0 0 1
related by related r re rel rela BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 --- 3 9 1 1 0 0 1
packing (Figure packing p pa pac pack BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 (). 3 8 1 1 0 0 1
activity and activity a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 -- 2 8 1 1 0 0 1
hydroxylphenylpyruvate (4-HPP) hydroxylphenylpyruvate h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 (-) 3 8 1 1 0 0 1
around proline-1. around a ar aro arou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 -., 3 8 1 1 0 0 1
of CD74 of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 9 1 1 0 0 1
proteins with proteins p pr pro prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 . 1 10 1 1 0 0 1
Despite their despite D De Des Desp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 , 1 9 1 1 0 0 1
just 34% just j ju jus just BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 (). 3 9 1 1 0 0 1
These sequence these T Th The Thes BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 8 1 1 0 0 1
interaction sites. interaction i in int inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 0 ., 2 9 1 1 0 0 1
inside the inside i in ins insi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 9 1 1 0 0 1
activity toward activity a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 --. 3 9 1 1 0 0 1
Moreover, MIF2 moreover, M Mo Mor More BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 ,/ 2 8 1 1 0 0 1
because it because b be bec beca BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 (), 3 8 1 1 0 0 1
interactions. 20,21 interactions. i in int inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 .,, 3 9 1 1 0 0 1
differences between differences d di dif diff BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 8 1 1 0 0 1
discovery of discovery d di dis disc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 10 1 1 0 0 1
members. members. members. m me mem memb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 . 1 1 1 1 0 0 1
Considerable efforts considerable C Co Con Cons BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 9 1 1 0 0 1
small-molecule inhibitors small-molecule s sm sma smal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 - 1 9 1 1 0 0 1
cancers. For cancers. c ca can canc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ., 2 9 1 1 0 0 1
dozens of dozens d do doz doze BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 -, 2 9 1 1 0 0 1
tautomerase active tautomerase t ta tau taut BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 . 1 9 1 1 0 0 1
are located are a ar are are BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 9 1 1 0 0 1
key roles key k ke key key BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 4 ,,- 3 9 1 1 0 0 1
binders of binders b bi bin bind BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 no 0 9 1 1 0 0 1
structural or structural s st str stru BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 no 0 9 1 1 0 0 1
CD74 binding cd74 C CD CD7 CD74 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 4 -., 3 9 1 1 0 0 1
the most the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 -() 3 9 1 1 0 0 1
not only not n no not not BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 no 0 9 1 1 0 0 1
significant suppression significant s si sig sign BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 no 0 9 1 1 0 0 1
and animal and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 , 1 9 1 1 0 0 1
of MIF-triggered of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 -. 2 8 1 1 0 0 1
recent study, recent r re rec rece BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 ,- 2 8 1 1 0 0 1
derivative can derivative d de der deri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 - 1 9 1 1 0 0 1
binding to binding b bi bin bind BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 ., 2 10 1 1 0 0 1
Jorgensen Lab jorgensen J Jo Jor Jorg BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 0 4 - 1 9 1 1 0 0 1
pyrazole-containing MIF pyrazole-containing p py pyr pyra BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 4 -, 2 9 1 1 0 0 1
potency at potency p po pot pote BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 .,, 3 9 1 1 0 0 1
potent MIF-targeted potent p po pot pote BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 -() 3 9 1 1 0 0 1
to remove to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 , 1 9 1 1 0 0 1
further expanded further f fu fur furt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 . 1 8 1 1 0 0 1
However, little however, H Ho How Howe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 4 , 1 9 1 1 0 0 1
on cancer on o on on on BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 no 0 9 1 1 0 0 1
and other and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 .--- 4 9 1 1 0 0 1
(4-IPP) is (4-ipp) ( (4 (4- (4-I BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 4 (-), 4 8 1 1 0 0 1
covalently binds covalently c co cov cova BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 4 - 1 9 1 1 0 0 1
tautomerase enzyme tautomerase t ta tau taut BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 4 . 1 9 1 1 0 0 1
However, 4-IPP however, H Ho How Howe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 4 ,- 2 8 1 1 0 0 1
an IC an a an an an BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 4 .,- 3 9 1 1 0 0 1
MIF with mif M MI MIF MIF BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 4 no 0 8 1 1 0 0 1
active site active a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 .,- 3 9 1 1 0 0 1
discovered the discovered d di dis disc BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 -(-)- 5 9 1 1 0 0 1
Figure 1. figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 8 ..()(:) 7 9 1 0 0 0 1
MIF2 (PDB mif2 M MI MIF MIF2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 8 (:).().() 9 8 1 0 0 0 1
tautomerase inhibitors. tautomerase t ta tau taut BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 8 .-.-.- 6 10 1 0 0 0 1
MIF2 inhibitor mif2 M MI MIF MIF2 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 8 . 1 5 1 0 0 0 1
Figure 2. figure F Fi Fig Figu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 10 .., 3 10 1 1 0 0 1
substrate. This substrate. s su sub subs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 10 .. 2 9 1 1 0 0 1
optimized. The optimized. o op opt opti BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 10 .-. 3 9 1 1 0 0 1
Journal of journal J Jo Jou Jour BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 11 no 0 10 1 1 0 0 0
pubs.acs.org/jmc pubs.acs.org/jmc pubs.acs.org/jmc p pu pub pubs BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 11 ../ 3 10 1 1 0 0 0
Article Article article A Ar Art Arti BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 11 no 0 4 1 1 0 0 0
https://doi.org/10.1021/acs.jmedchem.1c01598 https://doi.org/10.1021/acs.jmedchem.1c01598 https://doi.org/10.1021/acs.jmedchem.1c01598 h ht htt http BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 0 11 ://././.. 9 10 0 0 0 0 0
J. Med. j. J J. J. J. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 11 ...,,- 6 7 0 0 0 0 0
2060 2060 2060 2 20 206 2060 BLOCKSTART PAGEEND NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 0 11 no 0 10 0 0 0 0 0
2,5-pyridinedicarboxylic acid 2,5-pyridinedicarboxylic 2 2, 2,5 2,5- BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 0 ,-(-)- 6 9 0 1 0 0 1
ing, which ing, i in ing ing, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 , 1 8 0 1 0 0 1
tautomerase activity. tautomerase t ta tau taut BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 .,- 3 9 0 1 0 0 1
inhibit MIF2-CD74 inhibit i in inh inhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 -- 2 7 0 1 0 0 1
activation. To activation. a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 . 1 9 0 1 0 0 1
in cancer in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 0 , 1 9 0 1 0 0 1
MIF2 selective mif2 M MI MIF MIF2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 0 . 1 5 0 1 0 0 1
In this in I In In In BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 0 0 , 1 9 0 1 0 0 1
potent and potent p po pot pote BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 - 1 9 0 1 0 0 1
level potency level l le lev leve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 9 0 1 0 0 1
and cancer and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ()., 4 10 0 1 0 0 1
activity assay activity a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 9 0 1 0 0 1
inhibitors in inhibitors i in inh inhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 no 0 9 0 1 0 0 1
analysis. Subsequently, analysis. a an ana anal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 .,- 3 9 0 1 0 0 1
collections were collections c co col coll BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 9 0 1 0 0 1
chosen for chosen c ch cho chos BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ., 2 9 0 1 0 0 1
were prepared were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 9 0 1 0 0 1
tautomerase activity. tautomerase t ta tau taut BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 . 1 9 0 1 0 0 1
in two-dimensional in i in in in BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 3 -()-() 6 9 0 1 0 0 1
of non-small of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 -()., 5 10 0 1 0 0 1
the development the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 - 1 9 0 1 0 0 1
oriented research oriented o or ori orie BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 - 1 9 0 1 0 0 1
directed therapeutics. directed d di dir dire BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 . 1 3 0 1 0 0 1
■ RESULTS ■ ■ ■ ■ ■ BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 0 3 no 0 10 0 1 0 0 1
Optimization MIF2 optimization O Op Opt Opti BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 3 . 1 7 0 1 0 0 1
facilitate the facilitate f fa fac faci BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 no 0 9 0 1 0 0 1
inhibitors, a inhibitors, i in inh inhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 3 ,. 2 9 0 1 0 0 1
widely used widely w wi wid wide BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 no 0 8 0 1 0 0 1
inhibition is inhibition i in inh inhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 --, 3 8 0 1 0 0 1
which the which w wh whi whic BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 -- 2 8 0 1 0 0 1
tautomerization is tautomerization t ta tau taut BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 3 no 0 10 0 1 0 0 1
tested compound tested t te tes test BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 . 1 8 0 1 0 0 1
assess MIF2 assess a as ass asse BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 ., 2 8 0 1 0 0 1
catalytic activity catalytic c ca cat cata BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 -- 2 9 0 1 0 0 1
10 times 10 1 10 10 10 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 0 3 (). 3 9 0 1 0 0 1
Figure 3. figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 5 .-.()--- 8 9 1 0 0 0 1
reaction. The reaction. r re rea reac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 .---.()( 8 9 1 0 0 0 1
code: 6c5f) code: c co cod code BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 :)(:)-.() 9 9 1 0 0 0 1
phenylpyruvate in phenylpyruvate p ph phe phen BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 5 -()-().() 9 10 1 0 0 0 1
μM Cu μm μ μM μM μM BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 5 .(). 4 5 1 0 0 0 1
Table 1. table T Ta Tab Tabl BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 8 . 1 10 1 0 0 0 1
enzyme enzyme enzyme e en enz enzy BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 no 0 7 1 1 0 0 1
parameter parameter parameter p pa par para BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 no 0 10 1 1 0 0 1
PP PP pp P PP PP PP BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 8 no 0 3 1 1 0 0 1
4-CPP 4-CPP 4-cpp 4 4- 4-C 4-CP BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 8 - 1 6 1 1 0 0 1
4-HPP 4-HPP 4-hpp 4 4- 4-H 4-HP BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 8 - 1 6 1 1 0 0 1
4-MPP 4-MPP 4-mpp 4 4- 4-M 4-MP BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 8 - 1 6 1 1 0 0 1
MIF MIF mif M MI MIF MIF BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 8 no 0 1 1 1 0 0 1
K M k K K K K BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 8 () 2 3 1 1 0 0 1
0.76 ± 0.76 0 0. 0.7 0.76 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 8 .. 2 4 1 1 0 0 1
0.60 ± 0.60 0 0. 0.6 0.60 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 8 .. 2 4 1 1 0 0 1
0.94 ± 0.94 0 0. 0.9 0.94 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 8 .. 2 4 1 1 0 0 1
1.3 ± 1.3 1 1. 1.3 1.3 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 8 .. 2 3 1 1 0 0 1
k cat k k k k k BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 1 8 (-)# 4 5 1 1 0 0 1
14 ± 14 1 14 14 14 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 8 . 1 3 1 1 0 0 1
25 ± 25 2 25 25 25 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 8 . 1 3 1 1 0 0 1
25 ± 25 2 25 25 25 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 8 . 1 4 1 1 0 0 1
13 ± 13 1 13 13 13 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 8 . 1 3 1 1 0 0 1
k cat k k k k k BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 1 8 /(--) 5 10 1 1 0 0 1
1.9 1.9 1.9 1 1. 1.9 1.9 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 8 . 1 1 1 1 0 0 1
4.3 4.3 4.3 4 4. 4.3 4.3 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 8 . 1 1 1 1 0 0 1
2.6 2.6 2.6 2 2. 2.6 2.6 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 8 . 1 1 1 1 0 0 1
0.98 0.98 0.98 0 0. 0.9 0.98 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 8 . 1 1 1 1 0 0 1
MIF2 MIF2 mif2 M MI MIF MIF2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 8 no 0 1 1 1 0 0 1
K M k K K K K BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 8 () 2 3 1 1 0 0 1
2.4 ± 2.4 2 2. 2.4 2.4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 8 .. 2 3 1 1 0 0 1
2.17 ± 2.17 2 2. 2.1 2.17 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 8 .. 2 4 1 1 0 0 1
3.62 ± 3.62 3 3. 3.6 3.62 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 8 .. 2 4 1 1 0 0 1
6.7 ± 6.7 6 6. 6.7 6.7 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 8 .. 2 3 1 1 0 0 1
k cat k k k k k BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 1 8 (-) 3 4 1 1 0 0 1
132 ± 132 1 13 132 132 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 8 no 0 3 1 1 0 0 1
68 ± 68 6 68 68 68 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 8 . 1 3 1 1 0 0 1
13 ± 13 1 13 13 13 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 8 . 1 3 1 1 0 0 1
28 ± 28 2 28 28 28 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 8 . 1 3 1 1 0 0 1
k cat k k k k k BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 1 8 /(--) 5 10 1 1 0 0 1
5.5 5.5 5.5 5 5. 5.5 5.5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 8 . 1 1 1 1 0 0 1
3.2 3.2 3.2 3 3. 3.2 3.2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 8 . 1 1 1 1 0 0 1
0.37 0.37 0.37 0 0. 0.3 0.37 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 8 . 1 1 1 1 0 0 1
0.43 0.43 0.43 0 0. 0.4 0.43 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 8 . 1 1 1 1 0 0 1
Journal of journal J Jo Jou Jour BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 11 no 0 10 1 1 0 0 0
pubs.acs.org/jmc pubs.acs.org/jmc pubs.acs.org/jmc p pu pub pubs BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 11 ../ 3 10 1 1 0 0 0
Article Article article A Ar Art Arti BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 11 no 0 4 1 1 0 0 0
https://doi.org/10.1021/acs.jmedchem.1c01598 https://doi.org/10.1021/acs.jmedchem.1c01598 https://doi.org/10.1021/acs.jmedchem.1c01598 h ht htt http BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 1 11 ://././.. 9 10 0 0 0 0 0
J. Med. j. J J. J. J. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 11 ...,,- 6 7 0 0 0 0 0
2061 2061 2061 2 20 206 2061 BLOCKSTART PAGEEND NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 1 11 no 0 10 0 0 0 0 0
4-HPP unsuitable 4-hpp 4 4- 4-H 4-HP BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 0 - 1 8 1 1 0 0 1
activity assay activity a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 9 1 1 0 0 1
measurement times measurement m me mea meas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 . 1 9 1 1 0 0 1
different substrate. different d di dif diff BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 . 1 3 1 1 0 0 1
The structural the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 8 1 1 0 0 1
MIF2 were mif2 M MI MIF MIF2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 0 . 1 9 1 1 0 0 1
superimposition of superimposition s su sup supe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 no 0 8 1 1 0 0 1
complex 31 complex c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 -- 2 8 1 1 0 0 1
MIF2 overlaps mif2 M MI MIF MIF2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 0 -, 2 9 1 1 0 0 1
that the that t th tha that BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 9 1 1 0 0 1
spatial location spatial s sp spa spat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ., 2 9 1 1 0 0 1
able to able a ab abl able BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 9 1 1 0 0 1
of MIF of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 --, 3 8 1 1 0 0 1
Arg98 locates arg98 A Ar Arg Arg9 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 0 ( 1 9 1 1 0 0 1
3B). Accordingly, 3b). 3 3B 3B) 3B). BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 0 )., 3 8 1 1 0 0 1
different catalytic different d di dif diff BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 -- 2 9 1 1 0 0 1
HPP analogues hpp H HP HPP HPP BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 - 1 8 1 1 0 0 1
position. Therefore, position. p po pos posi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ., 2 9 1 1 0 0 1
for MIF2 for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 9 1 1 0 0 1
assay. Three assay. a as ass assa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 .-,-(- 6 8 1 1 0 0 1
MPP), 4-chlorophenylpyruvate mpp), M MP MPP MPP) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 ),-(-), 7 8 1 1 0 0 1
(PP), were (pp), ( (P (PP (PP) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 (), 3 9 1 1 0 0 1
MIF2 toward mif2 M MI MIF MIF2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 0 "". 3 9 1 1 0 0 1
measured parameters measured m me mea meas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 7 1 1 0 0 1
catalyzing PP, catalyzing c ca cat cata BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 ,-,-,--- 8 8 1 1 0 0 1
version are version v ve ver vers BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 .,.,.,.(), 10 8 1 1 0 0 1
respectively. These respectively. r re res resp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 . 1 9 1 1 0 0 1
values of values v va val valu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ., 2 10 1 1 0 0 1
and MIF2 and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ., 2 8 1 1 0 0 1
catalytic efficiency catalytic c ca cat cata BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 - 1 10 1 1 0 0 1
of MIF2, of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ,-. 3 8 1 1 0 0 1
contrast, MIF2 contrast, c co con cont BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ,- 2 9 1 1 0 0 1
around 3 around a ar aro arou BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 , 1 9 1 1 0 0 1
with the with w wi wit with BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 no 0 9 1 1 0 0 1
substrates. Interestingly, substrates. s su sub subs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 4 ., 2 8 1 1 0 0 1
MIF2 was mif2 M MI MIF MIF2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 4 ( 1 8 1 1 0 0 1
II) because ii) I II II) II) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 4 )., 3 10 1 1 0 0 1
identifies PP identifies i id ide iden BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 . 1 8 1 1 0 0 1
Next, PP next, N Ne Nex Next BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 4 , 1 8 1 1 0 0 1
in the in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 1 4 ., 2 9 1 1 0 0 1
solution in solution s so sol solu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 no 0 8 1 1 0 0 1
solution and solution s so sol solu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 no 0 8 1 1 0 0 1
preincubation. 35 preincubation. p pr pre prei BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 4 . 1 9 1 1 0 0 1
to the to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 -., 3 9 1 1 0 0 1
there were there t th the ther BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 ,.,.(/) 7 8 1 1 0 0 1
sulfoxide (DMSO), sulfoxide s su sul sulf BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 4 (), 3 7 1 1 0 0 1
inhibitor. The inhibitor. i in inh inhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 4 . 1 7 1 1 0 0 1
monitored at monitored m mo mon moni BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 no 0 8 1 1 0 0 1
the enzyme the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 (). 3 8 1 1 0 0 1
parameters were parameters p pa par para BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 no 0 9 1 1 0 0 1
or IC or o or or or BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 .(- 3 8 1 1 0 0 1
factor) of factor) f fa fac fact BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 4 ). 2 9 1 1 0 0 1
setup, indicating setup, s se set setu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 , 1 10 1 1 0 0 1
application in application a ap app appl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 --(.- 5 8 1 1 0 0 1
1). 36 1). 1 1) 1). 1). BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 4 )., 3 9 1 1 0 0 1
this MIF2 this t th thi this BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 no 0 9 1 1 0 0 1
in the in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 1 4 (). 3 7 1 1 0 0 1
Compounds Screening compounds C Co Com Comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 4 . 1 6 1 1 0 0 1
MIF2 tautomerase mif2 M MI MIF MIF2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 4 - 1 9 1 1 0 0 1
house available house h ho hou hous BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 1 4 no 0 8 1 1 0 0 1
chemical entities chemical c ch che chem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 no 0 8 1 1 0 0 1
(Figure 4A (figure ( (F (Fi (Fig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 4 (). 3 8 1 1 0 0 1
MIF2 activity mif2 M MI MIF MIF2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 4 no 0 8 1 1 0 0 1
excellent with excellent e ex exc exce BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 ( 1 8 1 1 0 0 1
coefficient) of coefficient) c co coe coef BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 4 ).. 3 10 1 1 0 0 1
as beyond as a as as as BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 ()., 4 9 1 1 0 0 1
Figure 4. figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 9 ..()- 5 10 1 1 0 0 1
for their for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 9 ..() 4 10 1 1 0 0 1
Structure of structure S St Str Stru BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 9 ().()-. 7 9 1 1 0 0 1
ΔTm depicts δtm Δ ΔT ΔTm ΔTm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 9 .()- 4 9 1 1 0 0 1
in the in i in in in BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 1 9 ().(). 6 7 1 1 0 0 1
Journal of journal J Jo Jou Jour BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 11 no 0 10 1 1 0 0 0
pubs.acs.org/jmc pubs.acs.org/jmc pubs.acs.org/jmc p pu pub pubs BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 11 ../ 3 10 1 1 0 0 0
Article Article article A Ar Art Arti BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 11 no 0 4 1 1 0 0 0
https://doi.org/10.1021/acs.jmedchem.1c01598 https://doi.org/10.1021/acs.jmedchem.1c01598 https://doi.org/10.1021/acs.jmedchem.1c01598 h ht htt http BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 1 11 ://././.. 9 10 0 0 0 0 0
J. Med. j. J J. J. J. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 11 ...,,- 6 7 0 0 0 0 0
2062 2062 2062 2 20 206 2062 BLOCKSTART PAGEEND NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 1 11 no 0 10 0 0 0 0 0
potential binding potential p po pot pote BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ,- 2 9 1 0 0 0 1
select hit select s se sel sele BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 -.() 4 9 1 0 0 0 1
exhibited good exhibited e ex exh exhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 - 1 9 1 0 0 0 1
tion activity tion t ti tio tion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 ()( 3 10 1 0 0 0 1
0.34) (Figure 0.34) 0 0. 0.3 0.34 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 0 .)().() 7 9 1 0 0 0 1
and MIF2, and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 , 1 9 1 0 0 0 1
orthogonal assay. orthogonal o or ort orth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 .() 3 9 1 0 0 0 1
MIF2 increased mif2 M MI MIF MIF2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 0 . 1 9 1 0 0 0 1
(3a) (Figure (3a) ( (3 (3a (3a) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 0 ()(),() 7 9 1 0 0 0 1
MIF2. Subsequently, mif2. M MI MIF MIF2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 0 ., 2 9 1 0 0 0 1
(3a) to (3a) ( (3 (3a (3a) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 0 ().- 4 9 1 0 0 0 1
show intersection show s sh sho show BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 (-), 4 10 1 0 0 0 1
R110 (3a) r110 R R1 R11 R110 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 0 ()- 3 9 1 0 0 0 1
pyruvate to pyruvate p py pyr pyru BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 (). 3 9 1 0 0 0 1
Taken together, taken T Ta Tak Take BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 ,() 3 9 1 0 0 0 1
tautomerase activity tautomerase t ta tau taut BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 , 1 9 1 0 0 0 1
R110 (3a) r110 R R1 R11 R110 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 0 () 2 9 1 0 0 0 1
development of development d de dev deve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 1 0 . 1 7 1 0 0 0 1
Design and design D De Des Desi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 . 1 7 1 0 0 0 1
between R110 between b be bet betw BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 (), 3 9 1 0 0 0 1
by docking by b by by by BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ()( 3 9 1 0 0 0 1
code: 6c5f). code: c co cod code BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 :). 3 9 1 0 0 0 1
Discovery Studio discovery D Di Dis Disc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 ..() 4 8 1 0 0 0 1
tautomerase active tautomerase t ta tau taut BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 no 0 9 1 0 0 0 1
energy-minimized (Figure energy-minimized e en ene ener BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 -().- 5 9 1 0 0 0 1
occupy similar occupy o oc occ occu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 2 . 1 9 1 1 0 0 1
that the that t th tha that BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 2 () 2 9 1 1 0 0 1
the hydrophobic the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 2 ,- 2 9 1 1 0 0 1
group is group g gr gro grou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 2 . 1 8 1 1 0 0 1
(3a) and (3a) ( (3 (3a (3a) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 2 () 2 8 1 1 0 0 1
forces, including forces, f fo for forc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 2 , 1 9 1 1 0 0 1
group and group g gr gro grou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 2 ,,,, 4 9 1 1 0 0 1
interactions between interactions i in int inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 2 , 1 8 1 1 0 0 1
MIF2. A mif2. M MI MIF MIF2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 2 .() 3 8 1 1 0 0 1
Lys109 of lys109 L Ly Lys Lys1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 2 . 1 9 1 1 0 0 1
unoccupied space unoccupied u un uno unoc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 2 no 0 9 1 1 0 0 1
butyl group butyl b bu but buty BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 2 ()., 4 9 1 1 0 0 1
these regions these t th the thes BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 2 -() 3 10 1 1 0 0 1
the aim the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 2 . 1 8 1 1 0 0 1
To optimize to T To To To BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 2 (), 3 8 1 1 0 0 1
constructed employing constructed c co con cons BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 2 - 1 9 1 1 0 0 1
as a as a as as as BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 2 -. 2 9 1 1 0 0 1
different methods different d di dif diff BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 2 - 1 8 1 1 0 0 1
k. Compounds k. k k. k. k. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 4 .-- 3 7 0 0 0 0 1
Gewald-reaction employing gewald-reaction G Ge Gew Gewa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 4 -,- 3 8 0 0 0 0 1
mides, and mides, m mi mid mide BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 4 , 1 10 0 0 0 0 1
18-56%. Compounds 18-56%. 1 18 18- 18-5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 4 -.- 3 7 0 0 0 0 1
condensation of condensation c co con cond BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 - 1 8 0 0 0 0 1
mides in mides m mi mid mide BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 4 no 0 8 0 0 0 0 1
corresponding intermediates, corresponding c co cor corr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 , 1 9 0 0 0 0 1
afford the afford a af aff affo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 -. 2 8 0 0 0 0 1
resulting 2-aminothiophenes resulting r re res resu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 - 1 8 0 0 0 0 1
acylchlorides to acylchlorides a ac acy acyl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 4 -- 2 8 0 0 0 0 1
thiophene products thiophene t th thi thio BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 4 --.- 4 8 0 0 0 0 1
aminothiophenes were aminothiophenes a am ami amin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 4 [,- 3 9 0 0 0 0 1
d]pyrimidine-2,4(1H,3H)-diones 5a-e d]pyrimidine-2,4(1h,3h)-diones d d] d]p d]py BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 4 ]-,(,)--,-- 11 8 0 0 0 0 1
midazole (CDI) midazole m mi mid mida BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 4 ()-. 4 9 0 0 0 0 1
The profiles the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 4 . 1 9 0 0 0 0 1
different retention different d di dif diff BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 no 0 8 0 0 0 0 1
opposite optical opposite o op opp oppo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 ( 1 9 0 0 0 0 1
S3). The s3). S S3 S3) S3). BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 4 ).- 3 8 0 0 0 0 1
resolution mass resolution r re res reso BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 () 2 8 0 0 0 0 1
and 5e and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 .- 2 9 0 0 0 0 1
i and i i i i i BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 1 4 -, 2 8 0 0 0 0 1
which the which w wh whi whic BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 - 1 8 0 0 0 0 1
aminothiophenes (6a-g) aminothiophenes a am ami amin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 4 (-) 3 8 0 0 0 0 1
were cyclized were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 no 0 8 0 0 0 0 1
yields of yields y yi yie yiel BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 -.- 3 8 0 0 0 0 1
condensation of condensation c co con cond BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 - 1 9 0 0 0 0 1
provide the provide p pr pro prov BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 -. 2 9 0 0 0 0 1
final products final f fi fin fina BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 , 1 9 0 0 0 0 1
structures were structures s st str stru BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 - 1 8 0 0 0 0 1
copy and copy c co cop copy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 - 1 7 0 0 0 0 1
spectrometry (LC-HRMS) spectrometry s sp spe spec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 4 (-)(). 6 8 0 0 0 0 1
purity of purity p pu pur puri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 no 0 8 0 0 0 0 1
high-performance liquid high-performance h hi hig high BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 -(). 4 7 0 0 0 0 1
Structure-Activity Relationships. structure-activity S St Str Stru BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 4 -.- 3 7 0 0 0 0 1
tency toward tency t te ten tenc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 4 no 0 8 0 0 0 0 1
compound collection compound c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 - 1 8 0 0 0 0 1
ase activity ase a as ase ase BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 4 no 0 9 0 0 0 0 1
2-4. The 2-4. 2 2- 2-4 2-4. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 4 -.- 3 9 0 0 0 0 1
of 47 of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 ., 2 9 0 0 0 0 1
the literature. the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 .() 3 9 0 0 0 0 1
IC 50 ic I IC IC IC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 1 4 .,- 3 8 0 0 0 0 1
exhibits enhanced exhibits e ex exh exhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 ... 3 9 0 0 0 0 1
Neither adding neither N Ne Nei Neit BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 4 - 1 9 0 0 0 0 1
(3d) nor (3d) ( (3 (3d (3d) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 4 ()() 4 9 0 0 0 0 1
activity of activity a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 ()., 4 9 0 0 0 0 1
with phenethyl with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 (),(--)(), 10 8 0 0 0 0 1
ethoxyethyl (3g), ethoxyethyl e et eth etho BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 4 (),-() 6 8 0 0 0 0 1
MIF2 inhibitory mif2 M MI MIF MIF2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 4 .- 2 8 0 0 0 0 1
with different with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 (-). 4 9 0 0 0 0 1
However, the however, H Ho How Howe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 4 , 1 9 0 0 0 0 1
substitution (3i-k) substitution s su sub subs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 (-), 4 9 0 0 0 0 1
2.6 ± 2.6 2 2. 2.6 2.6 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 4 ... 3 6 0 0 0 0 1
To investigate to T To To To BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 4 no 0 8 0 0 0 0 1
inhibitors, we inhibitors, i in inh inhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 4 ,[,-]- 6 8 0 0 0 0 1
pyrimidine-2,4(1H,3H)-diones using pyrimidine-2,4(1h,3h)-diones p py pyr pyri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 4 -,(,)- 6 9 0 0 0 0 1
bridge the bridge b br bri brid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 --. 3 9 0 0 0 0 1
of 5a of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 ,, 2 9 0 0 0 0 1
similar to similar s si sim simi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 ().-, 5 8 0 0 0 0 1
observed that observed o ob obs obse BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 , 1 8 0 0 0 0 1
group, at group, g gr gro grou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 , 1 10 0 0 0 0 1
is beneficial is i is is is BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 no 0 9 0 0 0 0 1
inhibitors. Thus, inhibitors. i in inh inhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 4 .,,.., 6 9 0 0 0 0 1
employed as employed e em emp empl BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 no 0 8 0 0 0 0 1
Figure 5. figure F Fi Fig Figu BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 11 .() 3 10 1 1 0 0 1
(thick sticks) (thick ( (t (th (thi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 11 ()(:). 6 9 1 1 0 0 1
binding pocket binding b bi bin bind BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 11 . 1 9 1 1 0 0 1
with Lys109 with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 11 . 1 9 1 1 0 0 1
employed for employed e em emp empl BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 11 ,. 2 9 1 1 0 0 1
Journal of journal J Jo Jou Jour BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 11 no 0 10 0 1 0 0 0
pubs.acs.org/jmc pubs.acs.org/jmc pubs.acs.org/jmc p pu pub pubs BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 11 ../ 3 10 0 1 0 0 0
Article Article article A Ar Art Arti BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 11 no 0 4 0 1 0 0 0
https://doi.org/10.1021/acs.jmedchem.1c01598 https://doi.org/10.1021/acs.jmedchem.1c01598 https://doi.org/10.1021/acs.jmedchem.1c01598 h ht htt http BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 2 11 ://././.. 9 10 0 0 0 0 0
J. Med. j. J J. J. J. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 11 ...,,- 6 7 0 0 0 0 0
2063 2063 2063 2 20 206 2063 BLOCKSTART PAGEEND NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 2 11 no 0 10 0 0 0 0 0
SARs. First, sars. S SA SAR SARs BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 0 .,- 3 10 0 1 0 0 1
benzyl group benzyl b be ben benz BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 ,. 2 9 0 1 0 0 1
Subsequently, we subsequently, S Su Sub Subs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 0 ,- 2 9 0 1 0 0 1
to the to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 , 1 9 0 1 0 0 1
both show both b bo bot both BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 ., 2 9 0 1 0 0 1
7d to 7d 7 7d 7d 7d BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 0 -. 2 9 0 1 0 0 1
Interestingly, all interestingly, I In Int Inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 0 ,(-) 4 10 0 1 0 0 1
phenyl ring phenyl p ph phe phen BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 .,- 3 9 0 1 0 0 1
CF 3 cf C CF CF CF BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 3 ()- 3 9 0 1 0 0 1
potency with potency p po pot pote BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 3 ... 3 9 0 1 0 0 1
group of group g gr gro grou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 3 (--), 5 8 0 1 0 0 1
achieved 5c, achieved a ac ach achi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 3 ,- 2 10 0 1 0 0 1
on MIF2 on o on on on BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 3 ... 3 9 0 1 0 0 1
However, the however, H Ho How Howe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 3 ,./(.), 7 9 0 1 0 0 1
which would which w wh whi whic BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 3 - 1 9 0 1 0 0 1
based assays. based b ba bas base BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 3 .,- 3 8 0 1 0 0 1
Scheme 1. scheme S Sc Sch Sche BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 6 . 1 10 0 1 0 0 1
a a a a a a a BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 2 6 no 0 10 0 0 0 0 1
Reagents and reagents R Re Rea Reag BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 7 :.(),,,;.(),,;(),,,;.,,,- 25 10 0 0 0 0 1
dimethylformamide (DMF), dimethylformamide d di dim dime BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 7 (),;.,. 7 3 0 0 0 0 1
Scheme 2. scheme S Sc Sch Sche BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 8 . 1 10 0 0 0 0 1
a a a a a a a BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 2 9 no 0 10 0 1 0 0 1
Reagents and reagents R Re Rea Reag BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 9 :.(),,,;(),,,;.()-,,;() 23 10 0 1 0 0 1
MeONa, reflux; meona, M Me MeO MeON BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 9 ,;.-,,,. 8 3 0 1 0 0 1
Journal of journal J Jo Jou Jour BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 10 no 0 10 0 1 0 0 0
pubs.acs.org/jmc pubs.acs.org/jmc pubs.acs.org/jmc p pu pub pubs BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 11 ../ 3 10 0 1 0 0 0
Article Article article A Ar Art Arti BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 11 no 0 4 0 1 0 0 0
https://doi.org/10.1021/acs.jmedchem.1c01598 https://doi.org/10.1021/acs.jmedchem.1c01598 https://doi.org/10.1021/acs.jmedchem.1c01598 h ht htt http BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 2 11 ://././.. 9 10 0 0 0 0 0
J. Med. j. J J. J. J. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 11 ...,,- 6 7 0 0 0 0 0
2064 2064 2064 2 20 206 2064 BLOCKSTART PAGEEND NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 2 11 no 0 10 0 0 0 0 0
branched enantiomers branched b br bra bran BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 () 2 10 0 0 0 0 1
and to and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 ., 2 10 0 0 0 0 1
have improved have h ha hav have BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 9 0 0 0 0 1
concentrations of concentrations c co con conc BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 /()/() 6 9 0 0 0 0 1
for 5d for f fo for for BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 ,., 3 7 0 0 0 0 1
comparable potency comparable c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 ,. 2 8 0 0 0 0 1
identified 5d identified i id ide iden BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 no 0 8 0 0 0 0 1
tautomerase with tautomerase t ta tau taut BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 1 no 0 10 0 0 0 0 1
studies. studies. studies. s st stu stud BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 . 1 1 0 0 0 0 1
In addition, in I In In In BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 2 1 ,[,-]- 6 7 0 0 0 0 1
pyrimidine-2,4(1H,3H)-dione (7d) pyrimidine-2,4(1h,3h)-dione p py pyr pyri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 1 -,(,)-()[,-]- 13 7 0 0 0 0 1
pyrimidin-4(1H)-one (8b) pyrimidin-4(1h)-one p py pyr pyri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 1 -()-() 6 8 0 0 0 0 1
an IC an a an an an BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 2 1 .(). 4 9 0 0 0 0 1
the meta-position the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 -() 3 8 0 0 0 0 1
potency of potency p po pot pote BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 .., 3 8 0 0 0 0 1
modifying the modifying m mo mod modi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 () 2 8 0 0 0 0 1
(8c) failed (8c) ( (8 (8c (8c) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 1 (). 3 7 0 0 0 0 1
Characterization of characterization C Ch Cha Char BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 1 . 1 7 0 0 0 0 1
inhibits MIF2 inhibits i in inh inhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 no 0 9 0 0 0 0 1
thermal stability thermal t th the ther BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 . 1 9 0 0 0 0 1
5d stabilizes 5d 5 5d 5d 5d BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 1 - 1 9 0 0 0 0 1
Scheme 3. scheme S Sc Sch Sche BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 7 . 1 10 0 1 0 0 1
a a a a a a a BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 2 8 no 0 10 0 0 0 0 1
Reagents and reagents R Re Rea Reag BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 8 :.,,,, 6 8 0 0 0 0 1
reflux; b. reflux; r re ref refl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 8 ;.(),,,;(), 11 10 0 0 0 0 1
EtOH, reflux; etoh, E Et EtO EtOH BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 8 ,;.,. 5 4 0 0 0 0 1
Table 2. table T Ta Tab Tabl BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 9 .- 2 10 0 0 0 0 1
Conversion Assay conversion C Co Con Conv BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 9 no 0 1 0 0 0 0 1
a# (n a# a a# a# a# BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 10 #(,). 5 10 0 1 0 0 1
Journal of journal J Jo Jou Jour BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 10 no 0 10 0 1 0 0 0
pubs.acs.org/jmc pubs.acs.org/jmc pubs.acs.org/jmc p pu pub pubs BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 11 ../ 3 10 0 1 0 0 0
Article Article article A Ar Art Arti BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 11 no 0 4 0 1 0 0 0
https://doi.org/10.1021/acs.jmedchem.1c01598 https://doi.org/10.1021/acs.jmedchem.1c01598 https://doi.org/10.1021/acs.jmedchem.1c01598 h ht htt http BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 2 11 ://././.. 9 10 0 1 0 0 0
J. Med. j. J J. J. J. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 11 ...,,- 6 7 0 1 0 0 0
2065 2065 2065 2 20 206 2065 BLOCKSTART PAGEEND NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 2 11 no 0 10 0 1 0 0 0
its melting its i it its its BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 - 1 9 0 1 0 0 1
DMSO control dmso D DM DMS DMSO BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 0 (). 3 9 0 1 0 0 1
increases by increases i in inc incr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 ., 2 9 0 1 0 0 1
binding between binding b bi bin bind BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 ., 2 7 0 1 0 0 1
subjected to subjected s su sub subj BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 . 1 9 0 1 0 0 1
The Lineweaver-Burk the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 0 - 1 9 0 1 0 0 1
by 5d, by b by by by BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 , 1 8 0 1 0 0 1
concentration (Figure concentration c co con conc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 (), 3 8 0 1 0 0 1
competition with competition c co com comp BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 . 1 10 0 1 0 0 1
Moreover, we moreover, M Mo Mor More BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 4 , 1 9 0 1 0 0 1
MIF2 tautomerase mif2 M MI MIF MIF2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 4 no 0 10 0 1 0 0 1
MIF tautomerase mif M MI MIF MIF BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 4 . 1 9 0 1 0 0 1
of MIF of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 4 , 1 9 0 1 0 0 1
than 50-fold than t th tha than BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 4 -(). 4 8 0 1 0 0 1
together, 5d together, t to tog toge BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 4 ,,, 3 9 0 1 0 0 1
MIF2. MIF2. mif2. M MI MIF MIF2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 4 . 1 0 0 1 0 0 1
Molecular Modeling molecular M Mo Mol Mole BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 4 no 0 7 0 1 0 0 1
and MIF2. and a an and and BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 4 .- 2 8 0 1 0 0 1
Table 3. table T Ta Tab Tabl BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 8 .[,-]-,(,)-- 12 10 0 1 0 0 1
Catalyzed PP catalyzed C Ca Cat Cata BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 8 no 0 2 0 1 0 0 1
a# (n a# a a# a# a# BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 9 #(,). 5 10 0 1 0 0 1
Journal of journal J Jo Jou Jour BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 10 no 0 10 0 1 0 0 0
pubs.acs.org/jmc pubs.acs.org/jmc pubs.acs.org/jmc p pu pub pubs BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 10 ../ 3 10 0 1 0 0 0
Article Article article A Ar Art Arti BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 10 no 0 4 0 1 0 0 0
https://doi.org/10.1021/acs.jmedchem.1c01598 https://doi.org/10.1021/acs.jmedchem.1c01598 https://doi.org/10.1021/acs.jmedchem.1c01598 h ht htt http BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 2 10 ://././.. 9 10 0 0 0 0 0
J. Med. j. J J. J. J. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 10 ...,,- 6 7 0 0 0 0 0
2066 2066 2066 2 20 206 2066 BLOCKSTART PAGEEND NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 2 11 no 0 10 0 0 0 0 0
relationships, a relationships, r re rel rela BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 , 1 8 1 0 0 0 1
inhibitor 5d inhibitor i in inh inhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 . 1 8 1 0 0 0 1
active site active a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 (:), 4 9 1 0 0 0 1
and energy and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 ().- 4 8 1 0 0 0 1
poses of poses p po pos pose BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 .,- 3 8 1 0 0 0 1
stacking between stacking s st sta stac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 () 2 8 1 0 0 0 1
preserved for preserved p pr pre pres BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 ., 2 8 1 0 0 0 1
a hydrogen a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 2 0 ,() 3 8 1 0 0 0 1
Lys109. Instead, lys109. L Ly Lys Lys1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 0 .,- 3 7 1 0 0 0 1
Lys109. Additionally, lys109. L Ly Lys Lys1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 0 ., 2 7 1 0 0 0 1
interactions with interactions i in int inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 ,,., 4 8 1 0 0 0 1
Pro1 and pro1 P Pr Pro Pro1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 0 no 0 8 1 0 0 0 1
that can that t th tha that BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 -. 2 8 1 0 0 0 1
interactions could interactions i in int inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 7 1 0 0 0 1
compared with compared c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 ()., 4 7 1 0 0 0 1
binding mode binding b bi bin bind BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 8 1 0 0 0 1
sheds light sheds s sh she shed BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 . 1 7 1 0 0 0 1
Antiproliferative Activity antiproliferative A An Ant Anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 0 . 1 8 1 0 0 0 1
of 5d of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 , 1 8 1 0 0 0 1
effect on effect e ef eff effe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 - 1 8 1 0 0 0 1
(NSCLC) cells. (nsclc) ( (N (NS (NSC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 0 ()., 4 9 1 0 0 0 1
cell viability cell c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 ().() 5 8 1 0 0 0 1
indicated that indicated i in ind indi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 9 1 0 0 0 1
concentration of concentration c co con conc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 ,,, 3 7 1 0 0 0 1
HCC827 cells hcc827 H HC HCC HCC8 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 0 . 1 7 1 0 0 0 1
antiproliferative effects antiproliferative a an ant anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 , 1 10 1 0 0 0 1
5d in 5d 5 5d 5d 5d BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 0 no 0 9 1 0 0 0 1
numbers by numbers n nu num numb BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 2 0 no 0 7 1 0 0 0 1
assay. The assay. a as ass assa BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 . 1 9 1 0 0 0 1
several types several s se sev seve BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 -(). 4 10 1 0 0 0 1
Table 4. table T Ta Tab Tabl BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 5 . 1 10 1 1 0 0 1
Thieno[2,3-d]pyrimidin-4(1H)-ones Determined thieno[2,3-d]pyrimidin-4(1h)-ones T Th Thi Thie BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 5 [,-]-()- 8 10 1 1 0 0 1
MIF2-Catalyzed PP mif2-catalyzed M MI MIF MIF2 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 5 - 1 7 1 1 0 0 1
a# (n a# a a# a# a# BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 6 #(,). 5 10 1 0 0 0 1
Figure 6. figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 6 ..()-. 6 10 1 1 0 0 1
concentration-dependent shift concentration-dependent c co con conc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 -.()-.() 8 10 1 1 0 0 1
with micromolar with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 . 1 9 1 1 0 0 1
triplicate samples triplicate t tr tri trip BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 .(,*.,**.***.). 15 6 1 1 0 0 1
Figure 7. figure F Fi Fig Figu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 8 .( 2 9 1 0 0 0 1
sticks) with sticks) s st sti stic BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 8 )(:). 5 9 1 0 0 0 1
pocket are pocket p po poc pock BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 8 . 1 9 1 0 0 0 1
Ser50 is ser50 S Se Ser Ser5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 8 .- 2 9 1 0 0 0 1
formed with formed f fo for form BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 8 . 1 10 1 0 0 0 1
was employed was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 8 no 0 7 1 0 0 0 1
preparation. preparation. preparation. p pr pre prep BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 8 . 1 1 1 0 0 0 1
Figure 8. figure F Fi Fig Figu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 9 . 1 9 1 0 0 0 1
cells lines cells c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 9 ,,,. 4 9 1 0 0 0 1
at a at a at at at BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 9 -. 2 9 1 0 0 0 1
overnight culturing, overnight o ov ove over BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 9 , 1 10 1 0 0 0 1
of 5d of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 9 ., 2 9 1 0 0 0 1
CyQUANT cell cyquant C Cy CyQ CyQU BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 9 - 1 8 1 0 0 0 1
treated control. treated t tr tre trea BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 9 . 1 9 1 0 0 0 1
with SD with w wi wit with BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 9 (). 3 2 1 0 0 0 1
Journal of journal J Jo Jou Jour BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 11 no 0 10 1 1 0 0 0
pubs.acs.org/jmc pubs.acs.org/jmc pubs.acs.org/jmc p pu pub pubs BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 11 ../ 3 10 1 1 0 0 0
Article Article article A Ar Art Arti BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 11 no 0 4 1 1 0 0 0
https://doi.org/10.1021/acs.jmedchem.1c01598 https://doi.org/10.1021/acs.jmedchem.1c01598 https://doi.org/10.1021/acs.jmedchem.1c01598 h ht htt http BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 2 11 ://././.. 9 10 1 1 0 0 0
J. Med. j. J J. J. J. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 11 ...,,- 6 7 1 1 0 0 0
2067 2067 2067 2 20 206 2067 BLOCKSTART PAGEEND NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 3 11 no 0 10 1 1 0 0 0
5d showed 5d 5 5d 5d 5d BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 no 0 9 1 1 0 0 1
about 90% about a ab abo abou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 ., 2 9 1 1 0 0 1
showing an showing s sh sho show BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 .. 2 10 1 1 0 0 1
of H1650, of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 ,,., 4 9 1 1 0 0 1
7.6, and 7.6, 7 7. 7.6 7.6, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 .,.,., 6 9 1 1 0 0 1
demonstrate that demonstrate d de dem demo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 10 1 1 0 0 1
of NSCLC of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 . 1 3 1 1 0 0 1
The inhibitory the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 9 1 1 0 0 1
cell lines cell c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 . 1 9 1 1 0 0 1
results of results r re res resu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 3 0 no 0 9 1 1 0 0 1
inhibited cell inhibited i in inh inhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 . 1 9 1 1 0 0 1
observed a observed o ob obs obse BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 - 1 9 1 1 0 0 1
and size and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 -- 2 8 1 1 0 0 1
controls (Figure controls c co con cont BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 (). 3 9 1 1 0 0 1
was quantified was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 . 1 8 1 1 0 0 1
suppressed colony suppressed s su sup supp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 - 1 9 1 1 0 0 1
around 90% around a ar aro arou BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 8 1 1 0 0 1
concentration of concentration c co con conc BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 (). 3 8 1 1 0 0 1
the efficacy the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 . 1 9 1 1 0 0 1
To gain to T To To To BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 3 - 1 9 1 1 0 0 1
in a in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 3 3 , 1 9 1 1 0 0 1
growth model, growth g gr gro grow BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 , 1 8 1 1 0 0 1
cells, 39 cells, c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 ,. 2 9 1 1 0 0 1
After 5-day after A Af Aft Afte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 3 -, 2 9 1 1 0 0 1
to treat to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 . 1 9 1 1 0 0 1
diameters of diameters d di dia diam BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 no 0 9 1 1 0 0 1
of the of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 . 1 10 1 1 0 0 1
of tumor of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 ().,, 5 9 1 1 0 0 1
μM concentrations μm μ μM μM μM BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 3 , 1 9 1 1 0 0 1
was reduced was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 ,,,. 4 9 1 1 0 0 1
indicate that indicate i in ind indi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 no 0 9 1 1 0 0 1
reduces the reduces r re red redu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 . 1 9 1 1 0 0 1
5d Arrests 5d 5 5d 5d 5d BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 3 / 1 8 1 1 0 0 1
Phase. The phase. P Ph Pha Phas BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 3 .- 2 9 1 1 0 0 1
Figure 9. figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 6 ..()- 5 9 1 0 0 0 1
plate (1000 plate p pl pla plat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 (/).()., 8 9 1 0 0 0 1
the cells the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 ...() 5 10 1 0 0 0 1
were dissolved were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 . 1 9 1 0 0 0 1
DMSO-treated control. dmso-treated D DM DMS DMSO BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 6 -.(,*.,**.***.). 16 9 1 0 0 0 1
Figure 10. figure F Fi Fig Figu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 8 ..- 3 9 1 1 0 0 1
bottom plate bottom b bo bot bott BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 8 (/)()., 7 10 1 1 0 0 1
indicated concentrations indicated i in ind indi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 8 ...() 5 8 1 1 0 0 1
Representative images representative R Re Rep Repr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 8 .:.() 5 9 1 1 0 0 1
NIS-Elements AR nis-elements N NI NIS NIS- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 8 -.,() 5 9 1 1 0 0 1
Prism8. Values prism8. P Pr Pri Pris BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 .(,*.,**.***.). 15 8 1 1 0 0 1
Journal of journal J Jo Jou Jour BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 11 no 0 10 1 1 0 0 0
pubs.acs.org/jmc pubs.acs.org/jmc pubs.acs.org/jmc p pu pub pubs BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 11 ../ 3 10 1 1 0 0 0
Article Article article A Ar Art Arti BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 11 no 0 4 1 1 0 0 0
https://doi.org/10.1021/acs.jmedchem.1c01598 https://doi.org/10.1021/acs.jmedchem.1c01598 https://doi.org/10.1021/acs.jmedchem.1c01598 h ht htt http BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 3 11 ://././.. 9 10 0 0 0 0 0
J. Med. j. J J. J. J. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 11 ...,,- 6 7 0 0 0 0 0
2068 2068 2068 2 20 206 2068 BLOCKSTART PAGEEND NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 3 11 no 0 10 0 0 0 0 0
was investigated was w wa was was BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 . 1 9 1 1 0 0 1
to different to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 10 1 1 0 0 1
analysis. The analysis. a an ana anal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 . 1 9 1 1 0 0 1
G 0 g G G G G BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 0 /-(). 5 9 1 1 0 0 1
A549 cells a549 A A5 A54 A549 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 /. 2 9 1 1 0 0 1
Upon treatment upon U Up Upo Upon BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 ,.,, 4 8 1 1 0 0 1
increased to increased i in inc incr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 ,,,. 4 10 1 1 0 0 1
that 5d that t th tha that BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 , 1 9 1 1 0 0 1
explanation for explanation e ex exp expl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 . 1 9 1 1 0 0 1
5d Inhibits 5d 5 5d 5d 5d BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 . 1 7 1 1 0 0 1
treatment on treatment t tr tre trea BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 - 1 9 1 1 0 0 1
assessing MIF2-induced assessing a as ass asse BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 -. 2 8 1 1 0 0 1
aim, MIF2 aim, a ai aim aim, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 , 1 7 1 1 0 0 1
stimulate A549 stimulate s st sti stim BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 ;, 2 7 1 1 0 0 1
phosphorylation of phosphorylation p ph pho phos BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 no 0 9 1 1 0 0 1
blot detection. blot b bl blo blot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 .- 2 8 1 1 0 0 1
ylation in ylation y yl yla ylat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 .-. 3 8 1 1 0 0 1
Treatment with treatment T Tr Tre Trea BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 - 1 8 1 1 0 0 1
dependent manner dependent d de dep depe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 (). 3 8 1 1 0 0 1
5d treatment 5d 5 5d 5d 5d BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 no 0 8 1 1 0 0 1
MIF2-stimulation. MIF2-stimulation. mif2-stimulation. M MI MIF MIF2 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 -. 2 2 1 1 0 0 1
■ DISCUSSION ■ ■ ■ ■ ■ BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 3 no 0 10 0 0 0 0 1
The overexpression the T Th The The BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 3 ,, 2 8 0 0 0 0 1
has been has h ha has has BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 .,, 3 10 0 0 0 0 1
MIF and mif M MI MIF MIF BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 3 no 0 7 0 0 0 0 1
treatment. A treatment. t tr tre trea BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 . 1 9 0 0 0 0 1
development of development d de dev deve BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 3 4 .- 2 9 1 1 0 0 1
theless, the theless, t th the thel BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 4 , 1 9 1 1 0 0 1
behind. Thus, behind. b be beh behi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 ., 2 8 1 1 0 0 1
small-molecule MIF2 small-molecule s sm sma smal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 - 1 9 1 1 0 0 1
therapy. therapy. therapy. t th the ther BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 . 1 1 1 1 0 0 1
To discover to T To To To BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 4 - 1 8 1 1 0 0 1
MIF2, we mif2, M MI MIF MIF2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 4 ,-, 3 8 1 1 0 0 1
which includes which w wh whi whic BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 ,, 2 8 1 1 0 0 1
relevant cellular relevant r re rel rele BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 ., 2 9 1 1 0 0 1
the 4-HPP the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 -. 2 8 1 1 0 0 1
enzymatic activity enzymatic e en enz enzy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 4 - 1 9 1 1 0 0 1
of 4-HPP, of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 -, 2 9 1 1 0 0 1
MIF. 17 mif. M MI MIF MIF. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 4 . 1 9 1 1 0 0 1
inside the inside i in ins insi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 no 0 8 1 1 0 0 1
contribute to contribute c co con cont BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 no 0 8 1 1 0 0 1
facilitate the facilitate f fa fac faci BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 no 0 10 1 1 0 0 1
ISO-1, which iso-1, I IS ISO ISO- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 4 -, 2 9 1 1 0 0 1
inhibit MIF2. inhibit i in inh inhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 .,- 3 7 1 1 0 0 1
tautomerization assay tautomerization t ta tau taut BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 4 . 1 8 1 1 0 0 1
This PP-based this T Th Thi This BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 4 -- 2 8 1 1 0 0 1
library, which library, l li lib libr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 ,' 2 9 1 1 0 0 1
low micromolar low l lo low low BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 3 4 . 1 9 1 1 0 0 1
optimization on optimization o op opt opti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 no 0 8 1 1 0 0 1
properties. properties. properties. p pr pro prop BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 . 1 1 1 1 0 0 1
The putative the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 4 no 0 8 1 1 0 0 1
chlorophenyl group chlorophenyl c ch chl chlo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 4 no 0 8 1 1 0 0 1
butyl group butyl b bu but buty BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 4 . 1 9 1 1 0 0 1
Figure 11. figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 8 ..(). 5 9 1 0 0 0 1
Representative cell representative R Re Rep Repr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 8 -.() 4 9 1 0 0 0 1
distribution of distribution d di dis dist BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 8 (/,,/).( 8 10 1 0 0 0 1
= 3, = = = = = BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 8 ,-/.*.**..). 12 8 1 0 0 0 1
Figure 12. figure F Fi Fig Figu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 9 .-.() 5 9 1 1 0 0 1
recombinant MIF2 recombinant r re rec reco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 9 ; 1 9 1 1 0 0 1
examined by examined e ex exa exam BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 9 -,--(). 7 9 1 1 0 0 1
representative western representative r re rep repr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 9 ().(): 6 10 1 1 0 0 1
control group. control c co con cont BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 9 .. 2 4 1 1 0 0 1
Journal of journal J Jo Jou Jour BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 11 no 0 10 1 1 0 0 0
pubs.acs.org/jmc pubs.acs.org/jmc pubs.acs.org/jmc p pu pub pubs BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 11 ../ 3 10 1 1 0 0 0
Article Article article A Ar Art Arti BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 11 no 0 4 1 1 0 0 0
https://doi.org/10.1021/acs.jmedchem.1c01598 https://doi.org/10.1021/acs.jmedchem.1c01598 https://doi.org/10.1021/acs.jmedchem.1c01598 h ht htt http BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 3 11 ://././.. 9 10 0 0 0 0 0
J. Med. j. J J. J. J. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 11 ...,,- 6 7 0 0 0 0 0
2069 2069 2069 2 20 206 2069 BLOCKSTART PAGEEND NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 3 11 no 0 10 0 0 0 0 0
chloro and chloro c ch chl chlo BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 ,-. 3 9 0 1 0 0 1
To exploit to T To To To BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 , 1 9 0 1 0 0 1
collection of collection c co col coll BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 8 0 1 0 0 1
binding was binding b bi bin bind BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 -. 2 8 0 1 0 0 1
observed that observed o ob obs obse BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 8 0 1 0 0 1
different substituents different d di dif diff BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 -, 2 8 0 1 0 0 1
(naphthalen-1-yl)methyl group (naphthalen-1-yl)methyl ( (n (na (nap BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 (--) 4 8 0 1 0 0 1
modification in modification m mo mod modi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 . 1 9 0 1 0 0 1
respective 2-aminothiophene respective r re res resp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 -- 2 8 0 1 0 0 1
sponding thienopyrimidione sponding s sp spo spon BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 ,. 2 8 0 1 0 0 1
μM. Thus, μm. μ μM μM. μM. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 .,- 3 9 0 1 0 0 1
the previously the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 - 1 8 0 1 0 0 1
to have to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 . 1 9 0 1 0 0 1
the solubility the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 , 1 8 0 1 0 0 1
introducing a introducing i in int intr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 , 1 8 0 1 0 0 1
improved solubility improved i im imp impr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 . 1 8 0 1 0 0 1
Notably, 5d notably, N No Not Nota BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 ,- 2 8 0 1 0 0 1
ing a ing i in ing ing BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 3 0 -. 2 9 0 1 0 0 1
Taken together, taken T Ta Tak Take BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 0 , 1 7 0 1 0 0 1
tautomerase inhibitor tautomerase t ta tau taut BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 no 0 7 0 1 0 0 1
optimal solubility, optimal o op opt opti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 , 1 8 0 1 0 0 1
systems. systems. systems. s sy sys syst BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 . 1 1 0 1 0 0 1
The effect the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 8 0 1 0 0 1
culture assays culture c cu cul cult BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 , 1 8 0 1 0 0 1
H1299, HCC827, h1299, H H1 H12 H129 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 3 0 ,,. 3 7 0 1 0 0 1
inhibition of inhibition i in inh inhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 10 0 1 0 0 1
cells at cells c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 - 1 8 0 1 0 0 1
clonogenic assay. clonogenic c cl clo clon BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 . 1 9 0 1 0 0 1
on a on o on on on BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 , 1 9 0 1 0 0 1
the main the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 , 1 9 0 1 0 0 1
layered assembly, layered l la lay laye BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 ,,, 3 9 0 1 0 0 1
nutrient gradients. nutrient n nu nut nutr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 ., 2 9 0 1 0 0 1
was reduced was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 . 1 8 0 1 0 0 1
demonstrate that demonstrate d de dem demo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 9 0 1 0 0 1
cell proliferation, cell c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 , 1 9 0 1 0 0 1
antiproliferation effect antiproliferation a an ant anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 -., 3 9 0 1 0 0 1
We also we W We We We BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 , 1 8 0 1 0 0 1
tautomerase inhibitors, tautomerase t ta tau taut BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 ,, 2 9 0 1 0 0 1
activity in activity a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 8 0 1 0 0 1
cancer cell cancer c ca can canc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 . 1 8 0 1 0 0 1
previous results previous p pr pre prev BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 - 1 8 0 1 0 0 1
growth more growth g gr gro grow BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 -. 2 8 0 1 0 0 1
together, our together, t to tog toge BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 , 1 9 0 1 0 0 1
the cell the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 , 1 9 0 1 0 0 1
with previous with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 - 1 7 0 1 0 0 1
systems. 41,44 systems. s sy sys syst BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 ., 2 2 0 1 0 0 1
A main a A A A A BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 3 0 no 0 8 0 1 0 0 1
continuous and continuous c co con cont BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 . 1 8 0 1 0 0 1
Treatment of treatment T Tr Tre Trea BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 9 0 1 0 0 1
G 0 g G G G G BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 0 /,. 3 10 0 1 0 0 1
MIF2 is mif2 M MI MIF MIF2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 no 0 9 0 1 0 0 1
cell cycle cell c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 ., 2 8 0 1 0 0 1
also observed also a al als also BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 7 0 1 0 0 1
signaling as signaling s si sig sign BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 -- 2 7 0 1 0 0 1
ylation. The ylation. y yl yla ylat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 .- 2 8 0 1 0 0 1
in line in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 3 0 - 1 8 0 1 0 0 1
MIF2 protein mif2 M MI MIF MIF2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 . 1 9 0 1 0 0 1
of ERK of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 -. 2 7 0 1 0 0 1
Collectively, these collectively, C Co Col Coll BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 , 1 8 0 1 0 0 1
cancer cell cancer c ca can canc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 9 0 1 0 0 1
ERK phosphorylation erk E ER ERK ERK BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 0 no 0 8 0 1 0 0 1
arrest. arrest. arrest. a ar arr arre BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 . 1 1 0 1 0 0 1
In conclusion, in I In In In BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 4 4 , 1 9 0 1 0 0 1
and structure-guided and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 4 - 1 10 0 1 0 0 1
the potent the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 4 .- 2 9 0 1 0 0 1
molar potency molar m mo mol mola BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 4 , 1 8 0 1 0 0 1
MIF tautomerase mif M MI MIF MIF BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 4 . 1 8 0 1 0 0 1
competition with competition c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 4 , 1 9 0 1 0 0 1
binding was binding b bi bin bind BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 4 no 0 9 0 1 0 0 1
improves the improves i im imp impr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 4 ., 2 9 0 1 0 0 1
demonstrated that demonstrated d de dem demo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 4 - 1 9 0 1 0 0 1
suppresses the suppresses s su sup supp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 4 no 0 8 0 1 0 0 1
cultures, which cultures, c cu cul cult BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 4 , 1 9 0 1 0 0 1
MAPK signaling mapk M MA MAP MAPK BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 4 , 1 8 0 1 0 0 1
validating MIF2 validating v va val vali BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 4 no 0 9 0 1 0 0 1
NSCLC patients. nsclc N NS NSC NSCL BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 4 ., 2 8 0 1 0 0 1
reported here reported r re rep repo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 4 no 0 9 0 1 0 0 1
of MIF2 of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 4 no 0 9 0 1 0 0 1
systems. systems. systems. s sy sys syst BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 4 . 1 1 0 1 0 0 1
■ EXPERIMENTAL ■ ■ ■ ■ ■ BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 5 no 0 10 0 0 0 0 1
General. All general. G Ge Gen Gene BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 5 . 1 8 0 0 0 0 1
Sigma-Aldrich, AK sigma-aldrich, S Si Sig Sigm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 5 -,,, 4 8 0 0 0 0 1
were used were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 .- 2 9 0 0 0 0 1
layer chromatography layer l la lay laye BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 () 2 9 0 0 0 0 1
used for used u us use used BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 . 1 7 0 0 0 0 1
conducted using conducted c co con cond BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 -(). 4 7 0 0 0 0 1
(500 MHz) (500 ( (5 (50 (500 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 5 ()() 4 8 0 0 0 0 1
Avance 500 avance A Av Ava Avan BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 5 . 1 9 0 0 0 0 1
parts per parts p pa par part BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 (), 3 8 0 0 0 0 1
example, CDCl example, e ex exa exam BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 ,:.().()- 9 9 0 0 0 0 1
d 6 d d d d d BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 4 5 :.().(). 8 8 0 0 0 0 1
multiplicity, the multiplicity, m mu mul mult BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 5 ,:(), 5 9 0 0 0 0 1
(doublet), dd (doublet), ( (d (do (dou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 5 (),(),(),(), 12 9 0 0 0 0 1
(multiplet). Coupling (multiplet). ( (m (mu (mul BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 5 ().(). 6 9 0 0 0 0 1
transform mass transform t tr tra tran BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 () 2 8 0 0 0 0 1
(ESI) on (esi) ( (E (ES (ESI BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 5 ()/- 4 8 0 0 0 0 1
mass spectrometer mass m ma mas mass BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 -. 2 9 0 0 0 0 1
Purity of purity P Pu Pur Puri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 5 no 0 8 0 0 0 0 1
analysis. The analysis. a an ana anal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 .- 2 9 0 0 0 0 1
published method. published p pu pub publ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 . 1 2 0 0 0 0 1
2-Amino-N-butyl-5-(4-chlorophenyl)thiophene-3-carboxamide 2-Amino-N-butyl-5-(4-chlorophenyl)thiophene-3-carboxamide 2-amino-n-butyl-5-(4-chlorophenyl)thiophene-3-carboxamide 2 2- 2-A 2-Am BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 5 -----(-)-- 10 8 0 0 0 0 1
(3a). The (3a). ( (3 (3a (3a) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 5 ().-- 5 9 0 0 0 0 1
prepared using prepared p pr pre prep BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 . 1 9 0 0 0 0 1
R110 (3a), r110 R R1 R11 R110 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 5 (),-(-)(,.,.) 13 9 0 0 0 0 1
EtOH (5 etoh E Et EtO EtOH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 4 5 ()--- 5 9 0 0 0 0 1
(2a, 0.31 (2a, ( (2 (2a (2a, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 5 (,.,.)., 8 9 0 0 0 0 1
(0.30 mL, (0.30 ( (0 (0. (0.3 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 5 (.,.),( 7 9 0 0 0 0 1
mg, 0.60 mg, m mg mg, mg, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 5 ,.).,. 6 9 0 0 0 0 1
After cooled after A Af Aft Afte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 5 , 1 8 0 0 0 0 1
using EtOAc using u us usi usin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 ()() 4 8 0 0 0 0 1
(2 × (2 ( (2 (2 (2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 5 ().. 4 9 0 0 0 0 1
After filtration, after A Af Aft Afte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 5 , 1 9 0 0 0 0 1
pressure and pressure p pr pre pres BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 , 1 9 0 0 0 0 1
with petroleum with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 /:(/).( 7 9 0 0 0 0 1
mg) was mg) m mg mg) mg) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 5 ),.( 4 9 0 0 0 0 1
MHz, DMSO-d mhz, M MH MHz MHz, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 5 ,-).(,.,),.(,),.(, 18 9 0 0 0 0 1
2H), 7.43-7.35 2h), 2 2H 2H) 2H), BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 5 ),.-.(,),.(,.,),.(,. 20 9 0 0 0 0 1
Hz, 2H), hz, H Hz Hz, Hz, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 5 ,),.-.(,),.(,.,). 17 8 0 0 0 0 1
(126 MHz, (126 ( (1 (12 (126 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 5 (,-).,.,.,.,., 14 8 0 0 0 0 1
125.09, 121.76, 125.09, 1 12 125 125. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 5 .,.,.,.,.,.,.,.., 17 9 0 0 0 0 1
calculated for calculated c ca cal calc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 []:.,.. 7 10 0 0 0 0 1
2-Amino-5-(4-bromophenyl)-N-butylthiophene-3-carboxamide 2-Amino-5-(4-bromophenyl)-N-butylthiophene-3-carboxamide 2-amino-5-(4-bromophenyl)-n-butylthiophene-3-carboxamide 2 2- 2-A 2-Am BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 5 ---(-)---- 10 7 0 0 0 0 1
(3b). 48 (3b). ( (3 (3b (3b) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 5 ().-(-)(.,.)- 13 8 0 0 0 0 1
butyl-2-cyanoacetamide (140 butyl-2-cyanoacetamide b bu but buty BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 5 --(,.) 6 9 0 0 0 0 1
following the following f fo fol foll BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 , 1 9 0 0 0 0 1
3b (97 3b 3 3b 3b 3b BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 5 (,).( 5 8 0 0 0 0 1
MHz, DMSO-d mhz, M MH MHz MHz, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 5 ,-).(,.,),.(,),.(, 18 9 0 0 0 0 1
8.6 Hz, 8.6 8 8. 8.6 8.6 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 5 .,),.(,.,),.(,.,),. 19 9 0 0 0 0 1
(m, 2H), (m, ( (m (m, (m, BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 5 (,),.(,),.(,.,).( 17 8 0 0 0 0 1
Journal of journal J Jo Jou Jour BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 11 no 0 10 0 1 0 0 0
pubs.acs.org/jmc pubs.acs.org/jmc pubs.acs.org/jmc p pu pub pubs BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 11 ../ 3 10 0 1 0 0 0
Article Article article A Ar Art Arti BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 11 no 0 4 0 1 0 0 0
https://doi.org/10.1021/acs.jmedchem.1c01598 https://doi.org/10.1021/acs.jmedchem.1c01598 https://doi.org/10.1021/acs.jmedchem.1c01598 h ht htt http BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 4 11 ://././.. 9 10 0 0 0 0 0
J. Med. j. J J. J. J. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 11 ...,,- 6 7 0 0 0 0 0
2070 2070 2070 2 20 207 2070 BLOCKSTART PAGEEND NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 4 11 no 0 10 0 0 0 0 0
MHz, DMSO-d mhz, M MH MHz MHz, BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 ,-).,.,.,.,.,.,., 17 9 0 1 0 0 1
118.7, 108.8, 118.7, 1 11 118 118. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 0 .,.,.,.,.,.., 13 8 0 1 0 0 1
C 15 c C C C C BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 0 []:,,,. 7 7 0 1 0 0 1
2-Amino-5-(4-chlorophenyl)-N-phenethylthiophene-3-carboxa- 2-Amino-5-(4-chlorophenyl)-N-phenethylthiophene-3-carboxa- 2-amino-5-(4-chlorophenyl)-n-phenethylthiophene-3-carboxa- 2 2- 2-A 2-Am BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 0 ---(-)----- 11 7 0 1 0 0 1
mide (3c). mide m mi mid mide BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 ().-(-)(,,.) 12 8 0 1 0 0 1
and 2-cyano-N-phenethylacetamide and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 ---(,,.) 8 8 0 1 0 0 1
reacted using reacted r re rea reac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 , 1 9 0 1 0 0 1
compound 3c compound c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 (,). 4 8 0 1 0 0 1
NMR (500 nmr N NM NMR NMR BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 (,-).(,.,),.(,), 16 9 0 1 0 0 1
7.52 (s, 7.52 7 7. 7.5 7.52 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 0 .(,),.(,.,),.(,.,),. 20 9 0 1 0 0 1
(t, J (t, ( (t (t, (t, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 (,.,),.(,.,.,),.-.(, 20 9 0 1 0 0 1
2H), 2.81 2h), 2 2H 2H) 2H), BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 0 ),.(,.,).(,-) 13 8 0 1 0 0 1
165.20, 161.29, 165.20, 1 16 165 165. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 0 .,.,.,.,.,.,.,., 16 8 0 1 0 0 1
128.39, 126.09, 128.39, 1 12 128 128. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 0 .,.,.,.,.,.,..():/ 18 9 0 1 0 0 1
357.15 [M 357.15 3 35 357 357. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 0 .[]. 4 2 0 1 0 0 1
2-Amino-5-phenyl-N-((tetrahydrofuran-3-yl)methyl)thiophene- 2-Amino-5-phenyl-N-((tetrahydrofuran-3-yl)methyl)thiophene- 2-amino-5-phenyl-n-((tetrahydrofuran-3-yl)methyl)thiophene- 2 2- 2-A 2-Am BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 0 -----((--))- 12 8 0 1 0 0 1
3-carboxamide (3e). 3-carboxamide 3 3- 3-c 3-ca BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 0 -().-(,,.) 10 8 0 1 0 0 1
and 2-cyano-N-((tetrahydrofuran-3-yl)methyl)acetamide and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 ---((--))(,, 12 9 0 1 0 0 1
0.50 mmol) 0.50 0 0. 0.5 0.50 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 0 .) 2 9 0 1 0 0 1
3a, affording 3a, 3 3a 3a, 3a, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 0 ,(,) 4 9 0 1 0 0 1
powder. 1 powder. p po pow powd BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 .(,-).(,.,), 12 8 0 1 0 0 1
7.67 (s, 7.67 7 7. 7.6 7.67 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 0 .(,),.(,),.(,.,),.(,. 21 9 0 1 0 0 1
Hz, 2H), hz, H Hz Hz, Hz, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 ,),.(,.,),.(,.,),.(, 20 9 0 1 0 0 1
= 7.1, = = = = = BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 0 .,.,),.(,.,),.(,.,), 20 9 0 1 0 0 1
1.91-1.77 (m, 1.91-1.77 1 1. 1.9 1.91 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 0 .-.(,),.-.(,).(, 16 7 0 1 0 0 1
DMSO-d 6 dmso-d D DM DMS DMSO BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 -).,.,.,.,.,.,., 16 9 0 1 0 0 1
120.97, 108.01, 120.97, 1 12 120 120. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 0 .,.,.,.,.,.,.., 15 9 0 1 0 0 1
for C for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 []:.,.. 7 8 0 1 0 0 1
2-Amino-N-octyl-5-phenylthiophene-3-carboxamide (3f). 2-amino-n-octyl-5-phenylthiophene-3-carboxamide 2 2- 2-A 2-Am BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 0 -------().-- 12 8 0 1 0 0 1
nylacetaldehyde (1d, nylacetaldehyde n ny nyl nyla BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 (,,.)---- 9 8 0 1 0 0 1
mide (2d, mide m mi mid mide BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 (,.,.) 6 9 0 1 0 0 1
to the to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 ,(,) 4 9 0 1 0 0 1
light yellowish light l li lig ligh BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 4 0 .(,-).(, 8 9 0 1 0 0 1
5.6 Hz, 5.6 5 5. 5.6 5.6 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 0 .,),.(,),.(,),.(,.,),. 22 9 0 1 0 0 1
(t, J (t, ( (t (t, (t, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 (,.,),.(,.,),.(,.,), 20 10 0 1 0 0 1
1.52-1.43 (m, 1.52-1.43 1 1. 1.5 1.52 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 0 .-.(,),.-.(,),.(,.,). 21 8 0 1 0 0 1
13 13 13 1 13 13 13 BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 4 3 no 0 10 0 0 0 0 1
C NMR c C C C C BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 3 (,-).,.,.,., 12 8 0 0 0 0 1
125.83, 123.63, 125.83, 1 12 125 125. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 3 .,.,.,.,.,.,.,.,., 18 9 0 0 0 0 1
28.74, 26.60, 28.74, 2 28 28. 28.7 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 3 .,.,.,..,[ 10 9 0 0 0 0 1
H] + h] H H] H] H] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 3 ]:.,.. 6 4 0 0 0 0 1
2-Amino-5-(4-chlorophenyl)-N-(2-ethoxyethyl)thiophene-3-car- 2-Amino-5-(4-chlorophenyl)-N-(2-ethoxyethyl)thiophene-3-car- 2-amino-5-(4-chlorophenyl)-n-(2-ethoxyethyl)thiophene-3-car- 2 2- 2-A 2-Am BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 3 ---(-)--(-)--- 14 8 0 0 0 0 1
boxamide (3g). boxamide b bo box boxa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 3 ().-(-)(,,. 11 8 0 0 0 0 1
mmol) and mmol) m mm mmo mmol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 3 )---(-)(,,. 11 8 0 0 0 0 1
mmol) were mmol) m mm mmo mmol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 3 ), 2 9 0 0 0 0 1
affording compound affording a af aff affo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 3 (,) 3 8 0 0 0 0 1
powder. 1 powder. p po pow powd BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 3 .(,).(,.,), 11 8 0 0 0 0 1
7.29 (d, 7.29 7 7. 7.2 7.29 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 3 .(,.,),.(,),.(,),.(,),. 23 10 0 0 0 0 1
(d, J (d, ( (d (d, (d, BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 3 (,.,),.(,.,),.(,.,). 20 10 0 0 0 0 1
13 13 13 1 13 13 13 BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 5 4 no 0 10 0 0 0 0 1
C NMR c C C C C BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 5 4 (,).,.,.,., 11 8 0 0 0 0 1
129.12, 125.94, 129.12, 1 12 129 129. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 4 .,.,.,.,.,.,.,.,.. 18 9 0 0 0 0 1
HRMS, calculated hrms, H HR HRM HRMS BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 4 ,[]:., 6 9 0 0 0 0 1
325.0773. 325.0773. 325.0773. 3 32 325 325. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 4 .. 2 1 0 0 0 0 1
2-Amino-N-(4-chlorophenethyl)-5-(4-chlorophenyl)thiophene-3- 2-Amino-N-(4-chlorophenethyl)-5-(4-chlorophenyl)thiophene-3- 2-amino-n-(4-chlorophenethyl)-5-(4-chlorophenyl)thiophene-3- 2 2- 2-A 2-Am BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 4 ---(-)--(-)-- 13 8 0 0 0 0 1
carboxamide (3h). carboxamide c ca car carb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 4 ().-(-)(,, 10 8 0 0 0 0 1
0.50 mmol) 0.50 0 0. 0.5 0.50 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 4 .)-(-)--(,., 12 9 0 0 0 0 1
0.50 mmol) 0.50 0 0. 0.5 0.50 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 4 .) 2 9 0 0 0 0 1
3a, affording 3a, 3 3a 3a, 3a, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 4 ,(,) 4 9 0 0 0 0 1
powder. 1 powder. p po pow powd BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 .(,-).(,.,), 12 9 0 0 0 0 1
7.60 (s, 7.60 7 7. 7.6 7.60 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 4 .(,),.(,),.(,.,),.(,. 21 9 0 0 0 0 1
Hz, 2H), hz, H Hz Hz, Hz, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 4 ,),.(,.,),.(,.,),.(, 20 10 0 0 0 0 1
= 7.1 = = = = = BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 5 4 .,),.(,.,).(, 13 8 0 0 0 0 1
DMSO-d 6 dmso-d D DM DMS DMSO BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 4 -).,.,.,.,.,.,., 16 9 0 0 0 0 1
129.01, 128.94, 129.01, 1 12 129 129. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 4 .,.,.,.,.,.,.,.. 16 9 0 0 0 0 1
(ESI): m/z (esi): ( (E (ES (ESI BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 4 ():/.[]. 8 4 0 0 0 0 1
2-Amino-N,4-dibutyl-5-(4-chlorophenyl)thiophene-3-carboxa- 2-Amino-N,4-dibutyl-5-(4-chlorophenyl)thiophene-3-carboxa- 2-amino-n,4-dibutyl-5-(4-chlorophenyl)thiophene-3-carboxa- 2 2- 2-A 2-Am BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 4 --,---(-)--- 12 8 0 0 0 0 1
mide (3d). mide m mi mid mide BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 4 ().-(-)--(,.,.) 15 9 0 0 0 0 1
and 2-(4-chlorophenyl)acetaldehyde and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 -(-)(,.,.) 10 8 0 0 0 0 1
dissolved in dissolved d di dis diss BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 ().,(. 6 9 0 0 0 0 1
mL, 2.0 ml, m mL mL, mL, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 4 ,.).,(.) 8 8 0 0 0 0 1
added. The added. a ad add adde BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 ., 2 9 0 0 0 0 1
the addition the t th the the BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 (,) 3 9 0 1 0 0 1
(3 × (3 ( (3 (3 (3 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 6 (). 3 8 0 1 0 0 1
NaOH solution naoh N Na NaO NaOH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 6 (,). 4 8 0 1 0 0 1
filtrated, and filtrated, f fi fil filt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 6 , 1 8 0 1 0 0 1
reduced pressure. reduced r re red redu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 .( 2 8 0 1 0 0 1
mL), and ml), m mL mL) mL), BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 6 ),(,.)(.). 10 9 0 1 0 0 1
reaction mixture reaction r re rea reac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 ., 2 8 0 1 0 0 1
diluted with diluted d di dil dilu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 ()() 4 8 0 1 0 0 1
brine (2 brine b br bri brin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 ()., 4 8 0 1 0 0 1
filtrated, and filtrated, f fi fil filt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 6 , 1 8 0 1 0 0 1
reduced pressure. reduced r re red redu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 .( 2 8 0 1 0 0 1
mg, yield mg, m mg mg, mg, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 6 ,): 3 8 0 1 0 0 1
30:1 (v/v) 30:1 3 30 30: 30:1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 6 :(/).(,-).(, 12 8 0 1 0 0 1
5.6 Hz, 5.6 5 5. 5.6 5.6 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 6 .,),.(,.,),.(,.,),. 19 9 0 1 0 0 1
(s, 2H), (s, ( (s (s, (s, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 6 (,),.(,.,),.-.(,),.-.(, 23 9 0 1 0 0 1
2H), 1.33 2h), 2 2H 2H) 2H), BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 6 ),.(,.,.,),.(,.,),.(, 21 9 0 1 0 0 1
J = j J J J J BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 5 6 .,),.(,.,).(, 13 8 0 1 0 0 1
DMSO-d 6 dmso-d D DM DMS DMSO BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 6 -).,.,.,.,.,.,., 16 9 0 1 0 0 1
117.17, 113.51, 117.17, 1 11 117 117. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 6 .,.,.,.,.,.,.,.,.,.. 20 9 0 1 0 0 1
HRMS, calculated hrms, H HR HRM HRMS BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 6 ,[]:., 6 9 0 1 0 0 1
365.1449. 365.1449. 365.1449. 3 36 365 365. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 5 6 .. 2 1 0 1 0 0 1
2-Amino-4-methyl-N-(naphthalen-1-ylmethyl)-5-( 3- 2-amino-4-methyl-n-(naphthalen-1-ylmethyl)-5-( 2 2- 2-A 2-Am BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 6 -----(--)--(- 13 6 0 1 0 0 1
(trifluoromethyl)phenyl)thiophene-3-carboxamide (3i). (trifluoromethyl)phenyl)thiophene-3-carboxamide ( (t (tr (tri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 6 ())--().-(- 11 7 0 1 0 0 1
(Trifluoromethyl)phenyl)propan-2-on (1e, (trifluoromethyl)phenyl)propan-2-on ( (T (Tr (Tri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 6 ())--(,.,.) 11 8 0 1 0 0 1
2-cyano-N-(naphthalen-1-ylmethyl)acetamide (2h, 2-cyano-n-(naphthalen-1-ylmethyl)acetamide 2 2- 2-c 2-cy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 6 ---(--)(,.,.) 13 8 0 1 0 0 1
were reacted were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 , 1 8 0 1 0 0 1
affording compound affording a af aff affo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 (,). 4 8 0 1 0 0 1
NMR (500 nmr N NM NMR NMR BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 6 (,).(,.,),.(,. 14 9 0 1 0 0 1
Hz, 1H), hz, H Hz Hz, Hz, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 6 ,),.(,.,),.-.(,),.(,), 22 9 0 1 0 0 1
5.07 (d, 5.07 5 5. 5.0 5.07 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 6 .(,.,),.(,).(,) 15 9 0 1 0 0 1
δ 166.2, δ δ δ δ δ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 5 6 .,.,.,.,.,.,.,.(,. 18 9 0 1 0 0 1
Hz), 129.1, hz), H Hz Hz) Hz), BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 6 ),.,.,.,.,.,.(,.),., 20 9 0 1 0 0 1
126.1 (q, 126.1 1 12 126 126. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 6 .(,.),.,.,.(,.),., 18 9 0 1 0 0 1
119.8, 112.1, 119.8, 1 11 119 119. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 6 .,.,.,..,[ 10 9 0 1 0 0 1
H] + h] H H] H] H] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 6 ]:.,.. 6 4 0 1 0 0 1
(R)-2-Amino-4-methyl-N-(1-(naphthalen-1-yl)ethyl)-5-(3- (R)-2-Amino-4-methyl-N-(1-(naphthalen-1-yl)ethyl)-5-(3- (r)-2-amino-4-methyl-n-(1-(naphthalen-1-yl)ethyl)-5-(3- ( (R (R) (R)- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 6 ()------(-(--))--(- 19 7 0 1 0 0 1
(trifluoromethyl)phenyl)thiophene-3-carboxamide (3j). (trifluoromethyl)phenyl)thiophene-3-carboxamide ( (t (tr (tri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 6 ())--().-(- 11 7 0 1 0 0 1
(Trifluoromethyl)phenyl)propan-2-on (1e, (trifluoromethyl)phenyl)propan-2-on ( (T (Tr (Tri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 6 ())--(,.,.) 11 8 0 1 0 0 1
(R)-2-cyano-N-(1-(naphthalen-1-yl)ethyl)acetamide (2i, (r)-2-cyano-n-(1-(naphthalen-1-yl)ethyl)acetamide ( (R (R) (R)- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 6 ()----(-(--))(,.,. 18 9 0 1 0 0 1
mmol) were mmol) m mm mmo mmol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 6 ), 2 9 0 1 0 0 1
affording compound affording a af aff affo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 (,). 4 8 0 1 0 0 1
NMR (500 nmr N NM NMR NMR BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 6 (,).(,.,),.(,. 14 9 0 1 0 0 1
Hz, 1H), hz, H Hz Hz, Hz, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 6 ,),.(,.,),.-.(,),.-.(, 22 9 0 1 0 0 1
3H), 2.19 3h), 3 3H 3H) 3H), BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 6 ),.(,),.(,.,).(, 16 8 0 1 0 0 1
CDCl 3 cdcl C CD CDC CDCl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 6 ).,.,.,.,.,.,.,.(, 18 10 0 1 0 0 1
20.7 Hz), 20.7 2 20 20. 20.7 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 6 .),.,.,.,.,.(,.),., 19 9 0 1 0 0 1
126.3, 126.3, 126.3, 1 12 126 126. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 6 .,.,.,.,.(,.),.,.,., 20 9 0 1 0 0 1
45.0, 21.4, 45.0, 4 45 45. 45.0 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 6 .,.,..,[]: 10 9 0 1 0 0 1
455.1399, found 455.1399, 4 45 455 455. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 5 6 .,.. 4 3 0 1 0 0 1
(S)-2-Amino-4-methyl-N-(1-(naphthalen-1-yl)ethyl)-5-(3- (S)-2-Amino-4-methyl-N-(1-(naphthalen-1-yl)ethyl)-5-(3- (s)-2-amino-4-methyl-n-(1-(naphthalen-1-yl)ethyl)-5-(3- ( (S (S) (S)- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 6 ()------(-(--))--(- 19 7 0 1 0 0 1
(trifluoromethyl)phenyl)thiophene-3-carboxamide (3k). (trifluoromethyl)phenyl)thiophene-3-carboxamide ( (t (tr (tri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 6 ())--().-(- 11 7 0 1 0 0 1
(Trifluoromethyl)phenyl)propan-2-on (1e, (trifluoromethyl)phenyl)propan-2-on ( (T (Tr (Tri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 6 ())--(,.,)()- 13 8 0 1 0 0 1
2-cyano-N-(1-(naphthalen-1-yl)ethyl)acetamide (2i, 2-cyano-n-(1-(naphthalen-1-yl)ethyl)acetamide 2 2- 2-c 2-cy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 6 ---(-(--))(,.,. 15 8 0 1 0 0 1
mmol) were mmol) m mm mmo mmol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 6 ) 1 8 0 1 0 0 1
3d, affording 3d, 3 3d 3d, 3d, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 6 ,(.,). 6 9 0 1 0 0 1
NMR (500 nmr N NM NMR NMR BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 6 (,).(,.,),.(,. 14 9 0 1 0 0 1
Hz, 1H), hz, H Hz Hz, Hz, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 6 ,),.(,.,),.-.(,),.-.(, 22 9 0 1 0 0 1
2H), 2.19 2h), 2 2H 2H) 2H), BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 6 ),.(,),.(,).(,) 15 8 0 1 0 0 1
165.4, 138.6, 165.4, 1 16 165 165. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 6 .,.,.,.,.,.,.,.,.,., 20 9 0 1 0 0 1
128.5, 126.7, 128.5, 1 12 128 128. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 6 .,.,.,.,.,.(,.),., 18 9 0 1 0 0 1
123.9, 123.7, 123.9, 1 12 123 123. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 6 .,.,.,.,.,.,.,.., 17 9 0 1 0 0 1
for C for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 []:.,.. 7 8 0 1 0 0 1
2-Acetamido-N-butyl-5-phenylthiophene-3-carboxamide (4a). 2-acetamido-n-butyl-5-phenylthiophene-3-carboxamide 2 2- 2-A 2-Ac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 6 -------(). 10 7 0 1 0 0 1
To a to T To To To BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 6 ------- 7 8 0 1 0 0 1
carboxamide (0.30 carboxamide c ca car carb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 6 (.,.)(), 8 8 0 1 0 0 1
(2.0 mmol) (2.0 ( (2 (2. (2.0 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 6 (.)(). 6 8 0 1 0 0 1
was stirred was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 ., 2 9 0 1 0 0 1
mixture was mixture m mi mix mixt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 () 2 8 0 1 0 0 1
washed with washed w wa was wash BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 (,),(), 7 8 0 1 0 0 1
(20 mL), (20 ( (2 (20 (20 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 6 (),(). 6 9 0 1 0 0 1
Journal of journal J Jo Jou Jour BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 11 no 0 10 0 1 0 0 0
pubs.acs.org/jmc pubs.acs.org/jmc pubs.acs.org/jmc p pu pub pubs BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 11 ../ 3 10 0 1 0 0 0
Article Article article A Ar Art Arti BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 11 no 0 4 0 1 0 0 0
https://doi.org/10.1021/acs.jmedchem.1c01598 https://doi.org/10.1021/acs.jmedchem.1c01598 https://doi.org/10.1021/acs.jmedchem.1c01598 h ht htt http BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 5 11 ://././.. 9 10 0 0 0 0 0
J. Med. j. J J. J. J. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 11 ...,,- 6 7 0 0 0 0 0
2071 2071 2071 2 20 207 2071 BLOCKSTART PAGEEND NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 5 11 no 0 10 0 0 0 0 0
dried over dried d dr dri drie BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 ., 2 9 0 1 0 0 1
reduced pressure. reduced r re red redu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 .( 2 8 0 1 0 0 1
mg, yield mg, m mg mg, mg, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 ,).(,-).(,), 12 8 0 1 0 0 1
8.39 (t, 8.39 8 8. 8.3 8.39 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 .(,.,),.(,),.(,.,),. 20 9 0 1 0 0 1
(t, J (t, ( (t (t, (t, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 (,.,),.(,.,),.(,.,), 20 9 0 1 0 0 1
2.22 (s, 2.22 2 2. 2.2 2.22 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 .(,),.(,.,),.(,.,),. 20 9 0 1 0 0 1
(t, J (t, ( (t (t, (t, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 (,.,).(,-)., 12 8 0 1 0 0 1
164.51, 144.58, 164.51, 1 16 164 164. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 .,.,.,.,.,.,.,., 16 8 0 1 0 0 1
115.85, 38.45, 115.85, 1 11 115 115. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 .,.,.,.,.,.., 13 8 0 1 0 0 1
C 17 c C C C C BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 5 0 []:.,.. 7 7 0 1 0 0 1
N-Butyl-2-butyramido-5-phenylthiophene-3-carboxamide N-Butyl-2-butyramido-5-phenylthiophene-3-carboxamide n-butyl-2-butyramido-5-phenylthiophene-3-carboxamide N N- N-B N-Bu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 ------- 7 7 0 1 0 0 1
(4b). 48 (4b). ( (4 (4b (4b) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 (). 3 9 0 1 0 0 1
synthesis of synthesis s sy syn synt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 .(, 3 9 0 1 0 0 1
44%). 1 44%). 4 44 44% 44%) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 ).(,-).(,),.(,. 15 8 0 1 0 0 1
Hz, 1H), hz, H Hz Hz, Hz, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 ,),.(,),.-.(,),.(,.,),. 23 9 0 1 0 0 1
(td, J (td, ( (t (td (td, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 (,.,.,),.(,.,.,),.(,. 21 9 0 1 0 0 1
Hz, 2H), hz, H Hz Hz, Hz, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 ,),.(,.,),.(,.,.,),.(, 22 10 0 1 0 0 1
= 7.3 = = = = = BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 5 0 .,),.(,.,.,).( 14 8 0 1 0 0 1
MHz, DMSO-d mhz, M MH MHz MHz, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 ,-).,.,.,.,.,.,., 17 8 0 1 0 0 1
124.8, 124.6, 124.8, 1 12 124 124. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 .,.,.,.,.,.,.,.,.,.,., 22 9 0 1 0 0 1
13.5. HRMS, 13.5. 1 13 13. 13.5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 ..,[]:., 8 10 0 1 0 0 1
345.1631. 345.1631. 345.1631. 3 34 345 345. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 5 0 .. 2 1 0 1 0 0 1
N-Butyl-2-heptanamido-5-phenylthiophene-3-carboxamide N-Butyl-2-heptanamido-5-phenylthiophene-3-carboxamide n-butyl-2-heptanamido-5-phenylthiophene-3-carboxamide N N- N-B N-Bu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 ------- 7 7 0 1 0 0 1
(4c). 4c (4c). ( (4 (4c (4c) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 (). 3 8 0 1 0 0 1
synthesis of synthesis s sy syn synt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 .(, 3 9 0 1 0 0 1
51%). 1 51%). 5 51 51% 51%) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 ).(,-).(,),.(, 14 8 0 1 0 0 1
5.6 Hz, 5.6 5 5. 5.6 5.6 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 .,),.(,),.(,.,),.(,. 20 9 0 1 0 0 1
Hz, 2H), hz, H Hz Hz, Hz, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 ,),.(,.,),.-.(,),.(,. 21 9 0 1 0 0 1
Hz, 2H), hz, H Hz Hz, Hz, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 ,),.(,.,),.(,.,),.(, 20 9 0 1 0 0 1
= 14.8, = = = = = BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 5 0 .,.,),.-.(,),.(,.,), 20 8 0 1 0 0 1
0.85 (s, 0.85 0 0. 0.8 0.85 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 .(,).(,-).,., 13 8 0 1 0 0 1
165.03, 145.02, 165.03, 1 16 165 165. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 .,.,.,.,.,.,.,.,., 18 9 0 1 0 0 1
36.15, 34.12, 36.15, 3 36 36. 36.1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 .,.,.,.,.,.,.,.,.,.. 20 9 0 1 0 0 1
HRMS, calculated hrms, H HR HRM HRMS BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 ,[]:., 6 9 0 1 0 0 1
401.2254. 401.2254. 401.2254. 4 40 401 401. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 5 0 .. 2 1 0 1 0 0 1
3-Butyl-6-phenylthieno[2,3-d]pyrimidine-2,4(1H,3H)-dione 3-Butyl-6-phenylthieno[2,3-d]pyrimidine-2,4(1H,3H)-dione 3-butyl-6-phenylthieno[2,3-d]pyrimidine-2,4(1h,3h)-dione 3 3- 3-B 3-Bu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 ---[,-]-,(,)- 13 7 0 1 0 0 1
(5a). 48 (5a). ( (5 (5a (5a) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 ().------- 10 8 0 1 0 0 1
carboxamide (0.3g, carboxamide c ca car carb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 (.,.)(),,-- 11 7 0 1 0 0 1
yldiimidazole (CDI, yldiimidazole y yl yld yldi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 (,.,.), 7 8 0 1 0 0 1
was refluxed was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 ., 2 8 0 1 0 0 1
reduce pressure reduce r re red redu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 () 2 8 0 1 0 0 1
residual mixture. residual r re res resi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 . 1 8 0 1 0 0 1
(25 mL) (25 ( (2 (25 (25 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 ()(). 5 8 0 1 0 0 1
over MgSO over o ov ove over BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 ., 2 9 0 1 0 0 1
was removed was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 . 1 7 0 1 0 0 1
purification was purification p pu pur puri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 :- 2 8 0 1 0 0 1
EtOAc 3:1 etoac E Et EtO EtOA BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 :(/), 5 8 0 1 0 0 1
obtained as obtained o ob obt obta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 ..(,-) 6 8 0 1 0 0 1
δ 7.66 δ δ δ δ δ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 5 0 .(,.,),.(,),.(,.,),. 20 9 0 1 0 0 1
(t, J (t, ( (t (t, (t, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 (,.,),.-.(,),.(,.,),. 21 9 0 1 0 0 1
(h, J (h, ( (h (h, (h, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 (,.,),.(,.,).(, 15 8 0 1 0 0 1
DMSO-d 6 dmso-d D DM DMS DMSO BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 -).,.,.,.,.,.,., 16 9 0 1 0 0 1
125.29, 118.10, 125.29, 1 12 125 125. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 .,.,.,.,.,.,.., 15 9 0 1 0 0 1
for C for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 []:.,.. 7 8 0 1 0 0 1
3-Allyl-6-(4-chlorophenyl)thieno[2,3-d]pyrimidine-2,4(1H,3H)- 3-Allyl-6-(4-chlorophenyl)thieno[2,3-d]pyrimidine-2,4(1H,3H)- 3-allyl-6-(4-chlorophenyl)thieno[2,3-d]pyrimidine-2,4(1h,3h)- 3 3- 3-A 3-Al BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 ---(-)[,-]-,(,)- 16 8 0 1 0 0 1
dione (5b). dione d di dio dion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 5 0 ().-----(-)--- 14 8 0 1 0 0 1
amide (0.30 amide a am ami amid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 (.,.)(.,.) 10 8 0 1 0 0 1
following a following f fo fol foll BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 no 0 9 0 1 0 0 1
126 mg 126 1 12 126 126 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 5 0 ..(,- 5 8 0 1 0 0 1
d 6 d d d d d BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 5 0 ).(,),.(,.,),.(,),.(, 21 9 0 1 0 0 1
= 8.4 = = = = = BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 5 0 .,),.(,.,.,),.-.(,), 20 8 0 1 0 0 1
4.45 (d, 4.45 4 4. 4.4 4.45 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 .(,.,).(,-)., 13 8 0 1 0 0 1
150.19, 149.97, 150.19, 1 15 150 150. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 .,.,.,.,.,.,.,., 16 8 0 1 0 0 1
118.89, 116.23, 118.89, 1 11 118 118. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 .,.,.,..():/.[]. 16 8 0 1 0 0 1
5-Methyl-3-(naphthalen-1-ylmethyl)-6-(3-(trifluoromethyl)- 5-Methyl-3-(naphthalen-1-ylmethyl)-6-(3-(trifluoromethyl)- 5-methyl-3-(naphthalen-1-ylmethyl)-6-(3-(trifluoromethyl)- 5 5- 5-M 5-Me BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 ---(--)--(-()- 14 7 0 1 0 0 1
phenyl)thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione (5c). phenyl)thieno[2,3-d]pyrimidine-2,4(1h,3h)-dione p ph phe phen BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 )[,-]-,(,)-().(, 16 8 0 1 0 0 1
0.10 mmol) 0.10 0 0. 0.1 0.10 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 .)(,.) 6 7 0 1 0 0 1
procedure similar procedure p pr pro proc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 ,( 2 9 0 1 0 0 1
mg, yield mg, m mg mg, mg, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 ,).(,-) 7 8 0 1 0 0 1
12.56 (s, 12.56 1 12 12. 12.5 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 .(,),.(,.,),.(,.,), 19 8 0 1 0 0 1
7.84-7.72 (m, 7.84-7.72 7 7. 7.8 7.84 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 6 .-.(,),.-.(,),.(,.,), 21 8 0 1 0 0 1
7.10 (d, 7.10 7 7. 7.1 7.10 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 6 .(,.,),.(,),.(,).( 18 8 0 1 0 0 1
MHz, DMSO-d mhz, M MH MHz MHz, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 6 ,-).,.,.,.,.(,.), 17 9 0 1 0 0 1
133.2, 132.2, 133.2, 1 13 133 133. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 6 .,.,.,.,.,.,.,.,.,., 20 9 0 1 0 0 1
126.4, 125.8, 126.4, 1 12 126 126. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 6 .,.,.,.,.(,.),.,., 18 8 0 1 0 0 1
113.8, 40.9, 113.8, 1 11 113 113. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 6 .,.,..,[]: 10 10 0 1 0 0 1
467.1036, found 467.1036, 4 46 467 467. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 6 6 .,.. 4 3 0 1 0 0 1
(R)-5-Methyl-3-(1-(naphthalen-1-yl)ethyl)-6-(3-(trifluoromethyl)- (R)-5-Methyl-3-(1-(naphthalen-1-yl)ethyl)-6-(3-(trifluoromethyl)- (r)-5-methyl-3-(1-(naphthalen-1-yl)ethyl)-6-(3-(trifluoromethyl)- ( (R (R) (R)- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 6 ()----(-(--))--(-()- 20 8 0 1 0 0 1
phenyl)thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione (5d). phenyl)thieno[2,3-d]pyrimidine-2,4(1h,3h)-dione p ph phe phen BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 6 )[,-]-,(,)-().(., 17 8 0 1 0 0 1
0.50 mmol) 0.50 0 0. 0.5 0.50 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 6 .)(.,.) 7 7 0 1 0 0 1
procedure similar procedure p pr pro proc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 ,( 2 8 0 1 0 0 1
mg, yield mg, m mg mg, mg, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 6 ,).(,) 6 8 0 1 0 0 1
11.27 (s, 11.27 1 11 11. 11.2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 6 .(,),.(,.,.,),.(,., 19 9 0 1 0 0 1
1H), 7.76 1h), 1 1H 1H) 1H), BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 6 ),.(,.,),.(,.,),.-.(, 21 9 0 1 0 0 1
2H), 7.53-7.49 2h), 2 2H 2H) 2H), BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 6 ),.-.(,),.-.(,),.(,., 21 8 0 1 0 0 1
1H), 2.56 1h), 1 1H 1H) 1H), BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 6 ),.(,),.(,.,).(, 16 8 0 1 0 0 1
CDCl 3 cdcl C CD CDC CDCl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 6 ).,.,.,.,.,.,.,.,., 19 9 0 1 0 0 1
131.5 (q, 131.5 1 13 131 131. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 6 .(,.),.,.,.,.,.,.,. 19 9 0 1 0 0 1
(q, J (q, ( (q (q, (q, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 6 (,.),.(,.),.,.,.(,. 19 9 0 1 0 0 1
Hz), 123.2, hz), H Hz Hz) Hz), BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 6 ),.,.,.,.,.., 13 7 0 1 0 0 1
C 26 c C C C C BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 6 []:.,.. 7 8 0 1 0 0 1
(S)-5-Methyl-3-(1-(naphthalen-1-yl)ethyl)-6-(3-(trifluoromethyl)- (S)-5-Methyl-3-(1-(naphthalen-1-yl)ethyl)-6-(3-(trifluoromethyl)- (s)-5-methyl-3-(1-(naphthalen-1-yl)ethyl)-6-(3-(trifluoromethyl)- ( (S (S) (S)- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 6 ()----(-(--))--(-()- 20 8 0 1 0 0 1
phenyl)thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione (5e). phenyl)thieno[2,3-d]pyrimidine-2,4(1h,3h)-dione p ph phe phen BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 6 )[,-]-,(,)-().(., 17 8 0 1 0 0 1
0.50 mmol) 0.50 0 0. 0.5 0.50 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 6 .)(.,.) 7 7 0 1 0 0 1
procedure similar procedure p pr pro proc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 ,( 2 8 0 1 0 0 1
mg, yield mg, m mg mg, mg, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 6 ,).(,) 6 9 0 1 0 0 1
11.13 (s, 11.13 1 11 11. 11.1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 6 .(,),.(,),.(,.,),.(,. 21 9 0 1 0 0 1
Hz, 1H), hz, H Hz Hz, Hz, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 6 ,),.(,.,),.(,.,),.(, 20 9 0 1 0 0 1
= 7.7 = = = = = BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 6 .,),.(,.,.,),.(,., 18 9 0 1 0 0 1
1H), 2.55 1h), 1 1H 1H) 1H), BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 6 ),.(,),.(,.,).(, 16 8 0 1 0 0 1
CDCl 3 cdcl C CD CDC CDCl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 6 ).,.,.,.,.,.,.,.,., 19 9 0 1 0 0 1
131.5 (q, 131.5 1 13 131 131. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 6 .(,.),.,.,.,.,.,.,., 20 9 0 1 0 0 1
126.0 (q, 126.0 1 12 126 126. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 6 .(,.),.,.,.(,.),.,., 20 9 0 1 0 0 1
47.9, 16.9, 47.9, 4 47 47. 47.9 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 6 .,.,..,[]: 10 9 0 1 0 0 1
481.1192, found 481.1192, 4 48 481 481. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 6 6 .,.. 4 3 0 1 0 0 1
Ethyl 2-Amino-4-methyl-5-phenylthiophene-3-carboxylate ethyl E Et Eth Ethy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 6 6 ------- 7 7 0 1 0 0 1
(6a). 49 (6a). ( (6 (6a (6a) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 6 ().(,.,), 9 8 0 1 0 0 1
cyanoacetate (0.5 cyanoacetate c cy cya cyan BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 6 (.,),(.,), 10 8 0 1 0 0 1
and acetic and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 (.,)() 6 8 0 1 0 0 1
reflux for reflux r re ref refl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 6 ,. 2 9 0 1 0 0 1
the mixture the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 , 1 7 0 1 0 0 1
concentrated in concentrated c co con conc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 . 1 8 0 1 0 0 1
NaHCO 3 nahco N Na NaH NaHC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 6 ()(). 5 7 0 1 0 0 1
extract was extract e ex ext extr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 ()(). 5 8 0 1 0 0 1
evaporation of evaporation e ev eva evap BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 , 1 9 0 1 0 0 1
column chromatography column c co col colu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 -, 2 8 0 1 0 0 1
dissolved in dissolved d di dis diss BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 (). 3 8 0 1 0 0 1
(0.13 g, (0.13 ( (0 (0. (0.1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 6 (.,.)(.,), 10 8 0 1 0 0 1
resulting mixture resulting r re res resu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 . 1 9 0 1 0 0 1
solvent in solvent s so sol solv BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 , 1 9 0 1 0 0 1
CHCl 3 chcl C CH CHC CHCl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 6 (). 3 8 0 1 0 0 1
with brine with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 ()(). 5 7 0 1 0 0 1
concentrated in concentrated c co con conc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 , 1 8 0 1 0 0 1
CHCl 3 chcl C CH CHC CHCl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 6 (.,). 5 8 0 1 0 0 1
(500 MHz, (500 ( (5 (50 (500 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 6 (,-).(,.,),.(,),. 17 8 0 1 0 0 1
(d, J (d, ( (d (d, (d, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 6 (,.,),.(,.,),.(,.,), 20 9 0 1 0 0 1
1.34 (t, 1.34 1 1. 1.3 1.34 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 6 .(,.,). 7 3 0 1 0 0 1
Ethyl 2-Amino-5-(4-chlorophenyl)-4-methylthiophene-3-carbox- ethyl E Et Eth Ethy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 6 6 ---(-)----- 11 7 0 1 0 0 1
ylate (6b). ylate y yl yla ylat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 6 ().-(,.,) 9 8 0 1 0 0 1
cyanoacetate (0.5 cyanoacetate c cy cya cyan BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 6 (.,) 4 8 0 1 0 0 1
to the to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 ,(.,) 5 9 0 1 0 0 1
brown solid. brown b br bro brow BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 6 6 .(,).(,.,), 11 8 0 1 0 0 1
7.27 (d, 7.27 7 7. 7.2 7.27 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 6 .(,.,),.(,),.-.(,),.(, 22 8 0 1 0 0 1
3H), 1.37 3h), 3 3H 3H) 3H), BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 6 ),.(,.,). 9 4 0 1 0 0 1
Ethyl 2-Amino-5-(3,4-dichlorophenyl)-4-methylthiophene-3-car- ethyl E Et Eth Ethy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 6 6 ---(,-)----- 12 8 0 1 0 0 1
boxylate (6c). boxylate b bo box boxy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 6 ().-(,-)--(,., 14 8 0 1 0 0 1
mmol) and mmol) m mm mmo mmol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 6 )(.,) 5 8 0 1 0 0 1
procedure similar procedure p pr pro proc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 ,(. 3 9 0 1 0 0 1
g, yield g, g g, g, g, BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 6 ,).(,-) 7 8 0 1 0 0 1
Journal of journal J Jo Jou Jour BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 11 no 0 10 0 1 0 0 0
pubs.acs.org/jmc pubs.acs.org/jmc pubs.acs.org/jmc p pu pub pubs BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 11 ../ 3 10 0 1 0 0 0
Article Article article A Ar Art Arti BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 11 no 0 4 0 1 0 0 0
https://doi.org/10.1021/acs.jmedchem.1c01598 https://doi.org/10.1021/acs.jmedchem.1c01598 https://doi.org/10.1021/acs.jmedchem.1c01598 h ht htt http BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 7 11 ://././.. 9 10 0 0 0 0 0
J. Med. j. J J. J. J. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 11 ...,,- 6 7 0 0 0 0 0
2072 2072 2072 2 20 207 2072 BLOCKSTART PAGEEND NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 7 11 no 0 10 0 0 0 0 0
7.54 (s, 7.54 7 7. 7.5 7.54 BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .(,),.(,.,),.(,.,),. 20 9 0 1 0 0 1
(q, J (q, ( (q (q, (q, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 (,.,),.(,),.(,.,). 18 8 0 1 0 0 1
Ethyl 2-Amino-5-(2,4-dichlorophenyl)-4-methylthiophene-3-car- ethyl E Et Eth Ethy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 7 0 ---(,-)----- 12 8 0 1 0 0 1
boxylate (6d). boxylate b bo box boxy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 ().-(,-)--(,., 14 8 0 1 0 0 1
mmol) and mmol) m mm mmo mmol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 )(.,) 5 8 0 1 0 0 1
procedure similar procedure p pr pro proc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 ,(. 3 9 0 1 0 0 1
g, yield g, g g, g, g, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 ,).(,-) 7 8 0 1 0 0 1
7.72 (d, 7.72 7 7. 7.7 7.72 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .(,.,),.-.(,),.(,., 19 8 0 1 0 0 1
2H), 1.99 2h), 2 2H 2H) 2H), BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 ),.(,),.(,.,). 14 6 0 1 0 0 1
Ethyl 2-Amino-4-methyl-5-(3-(trifluoromethyl)phenyl)- ethyl E Et Eth Ethy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 7 0 -----(-())- 11 7 0 1 0 0 1
thiophene-3-carboxylate (6e). thiophene-3-carboxylate t th thi thio BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 --().(.,) 9 8 0 1 0 0 1
cyanoacetate (0.5 cyanoacetate c cy cya cyan BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 (.,) 4 9 0 1 0 0 1
to the to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 ,(.,) 5 9 0 1 0 0 1
brown solid. brown b br bro brow BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 7 0 .(,-).(,),. 11 8 0 1 0 0 1
(s, 1H), (s, ( (s (s, (s, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 (,),.(,),.(,.,),.(,),.(, 24 10 0 1 0 0 1
= 7.1 = = = = = BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 0 .,). 4 2 0 1 0 0 1
Ethyl 2-Amino-5-(benzo[d][1,3]dioxol-5-yl)-4-methylthiophene- ethyl E Et Eth Ethy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 7 0 ---([][,]--)--- 15 8 0 1 0 0 1
3-carboxylate (6f). 3-carboxylate 3 3- 3-c 3-ca BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 -().-([][,]--)--(, 18 8 0 1 0 0 1
0.3 mL, 0.3 0 0. 0.3 0.3 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,)(.,) 7 9 0 1 0 0 1
using a using u us usi usin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 , 1 9 0 1 0 0 1
6b (0.2 6b 6 6b 6b 6b BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 (.,).(,) 8 9 0 1 0 0 1
7.74 (s, 7.74 7 7. 7.7 7.74 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .(,),.(,.,),.(,.,),. 20 9 0 1 0 0 1
(s, 2H), (s, ( (s (s, (s, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 (,),.(,),.(,.,),.(,),.(, 24 10 0 1 0 0 1
= 6.5 = = = = = BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 0 .,). 4 2 0 1 0 0 1
Ethyl 2-Amino-5-(4-fluorophenyl)-4-methylthiophene-3-carbox- ethyl E Et Eth Ethy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 7 0 ---(-)----- 11 8 0 1 0 0 1
ylate (6g). ylate y yl yla ylat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 ().-([][,]--)--(,., 19 9 0 1 0 0 1
5.0 mmol) 5.0 5 5. 5.0 5.0 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .)(.,.) 7 8 0 1 0 0 1
using a using u us usi usin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 , 1 9 0 1 0 0 1
6b (0.81 6b 6 6b 6b 6b BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 (.,).(, 7 7 0 1 0 0 1
methanol-d 4 methanol-d m me met meth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 -).-.(,),.-.(,),.(, 19 9 0 1 0 0 1
7.1 Hz, 7.1 7 7. 7.1 7.1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,),.(,),.(,.,). 16 7 0 1 0 0 1
Synthesis of synthesis S Sy Syn Synt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 0 -.--,-[,-]- 11 7 0 1 0 0 1
pyrimidine-2,4(1H,3H)-dione (7a). pyrimidine-2,4(1h,3h)-dione p py pyr pyri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 -,(,)-().(. 11 9 0 1 0 0 1
g, 1 g, g g, g, g, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 ,)(),(.,. 9 8 0 1 0 0 1
mmol) was mmol) m mm mmo mmol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 ). 2 8 0 1 0 0 1
mixture was mixture m mi mix mixt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 , 1 8 0 1 0 0 1
suspended in suspended s su sus susp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 ()., 4 7 0 1 0 0 1
methoxide (0.6 methoxide m me met meth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 (.,) 4 9 0 1 0 0 1
stirred for stirred s st sti stir BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 ., 2 9 0 1 0 0 1
acidified with acidified a ac aci acid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 (). 3 9 0 1 0 0 1
The organic the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 0 , 1 8 0 1 0 0 1
the precipitate the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 . 1 9 0 1 0 0 1
methanol and methanol m me met meth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 : 1 7 0 1 0 0 1
(100:1) as (100:1) ( (1 (10 (100 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 (:). 4 9 0 1 0 0 1
(135 mg, (135 ( (1 (13 (135 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 (,).(,-).(, 11 8 0 1 0 0 1
1H), 7.51-7.39 1h), 1 1H 1H) 1H), BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 ),.-.(,),.-.(,),.(,). 21 8 0 1 0 0 1
(126 MHz, (126 ( (1 (12 (126 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 (,-).,.,.,.,., 14 8 0 1 0 0 1
129.83, 129.22, 129.83, 1 12 129 129. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,.,.,.,.,.,.,., 16 8 0 1 0 0 1
114.19, 14.15. 114.19, 1 11 114 114. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,..,[]: 8 9 0 1 0 0 1
335.0849, found 335.0849, 3 33 335 335. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,.. 4 3 0 1 0 0 1
3-Benzyl-5-methyl-6-phenylthieno[2,3-d]pyrimidine-2,4(1H,3H)- 3-Benzyl-5-methyl-6-phenylthieno[2,3-d]pyrimidine-2,4(1H,3H)- 3-benzyl-5-methyl-6-phenylthieno[2,3-d]pyrimidine-2,4(1h,3h)- 3 3- 3-B 3-Be BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 -----[,-]-,(,)- 15 8 0 1 0 0 1
dione (7b). dione d di dio dion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 7 0 ().(.,)(.,. 11 8 0 1 0 0 1
mmol) were mmol) m mm mmo mmol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 ), 2 9 0 1 0 0 1
affording compound affording a af aff affo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 (,). 4 8 0 1 0 0 1
NMR (500 nmr N NM NMR NMR BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 (,-).(,),.-.(,), 16 8 0 1 0 0 1
7.39 (t, 7.39 7 7. 7.3 7.39 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .(,.,),.-.(,),.-.(,), 21 8 0 1 0 0 1
5.04 (s, 5.04 5 5. 5.0 5.04 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .(,),.(,).(,-) 14 8 0 1 0 0 1
159.19, 150.43, 159.19, 1 15 159 159. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,.,.,.,.,.,.,., 16 8 0 1 0 0 1
128.34, 127.97, 128.34, 1 12 128 128. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,.,.,.,.,.,.,.., 17 9 0 1 0 0 1
calculated for calculated c ca cal calc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 []:.,.. 7 9 0 1 0 0 1
6-(4-Chlorophenyl)-5-methyl-3-phenylthieno[2,3-d]pyrimidine- 6-(4-Chlorophenyl)-5-methyl-3-phenylthieno[2,3-d]pyrimidine- 6-(4-chlorophenyl)-5-methyl-3-phenylthieno[2,3-d]pyrimidine- 6 6- 6-( 6-(4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 -(-)----[,-]- 13 8 0 1 0 0 1
2,4(1H,3H)-dione (7c). 2,4(1h,3h)-dione 2 2, 2,4 2,4( BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 ,(,)-().(.,)(. 14 9 0 1 0 0 1
mL, 1.5 ml, m mL mL, mL, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 ,.) 3 9 0 1 0 0 1
of 7a, of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 ,(,). 5 9 0 1 0 0 1
NMR (500 nmr N NM NMR NMR BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 (,-).(,),.(,., 14 8 0 1 0 0 1
2H), 7.51-7.46 2h), 2 2H 2H) 2H), BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 ),.-.(,),.(,.,),.(,., 21 9 0 1 0 0 1
2H), 2.40 2h), 2 2H 2H) 2H), BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 ),.(,).(,-)., 13 7 0 1 0 0 1
151.48, 150.55, 151.48, 1 15 151 151. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,.,.,.,.,.,.,., 16 8 0 1 0 0 1
131.00, 129.65, 131.00, 1 13 131 131. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,.,.,.,.,..():/. 17 9 0 1 0 0 1
[M + [m [ [M [M [M BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 []. 3 1 0 1 0 0 1
3-Benzyl-6-(4-chlorophenyl)-5-methylthieno[2,3-d]pyrimidine- 3-Benzyl-6-(4-chlorophenyl)-5-methylthieno[2,3-d]pyrimidine- 3-benzyl-6-(4-chlorophenyl)-5-methylthieno[2,3-d]pyrimidine- 3 3- 3-B 3-Be BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 ---(-)--[,-]- 13 7 0 1 0 0 1
2,4(1H,3H)-dione (7d). 2,4(1h,3h)-dione 2 2, 2,4 2,4( BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 ,(,)-().(.,.) 13 8 0 1 0 0 1
(0.2 mL, (0.2 ( (0 (0. (0.2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 (.,.) 5 8 0 1 0 0 1
synthesis of synthesis s sy syn synt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 ,(,) 4 8 0 1 0 0 1
solid. 1 solid. s so sol soli BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 .(,-).(,),.(, 13 8 0 1 0 0 1
6.1 Hz, 6.1 6 6. 6.1 6.1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 .,),.(,.,),.-.(,),.(, 21 8 0 1 0 0 1
2H), 2.43 2h), 2 2H 2H) 2H), BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 ),.(,).(,-)., 13 7 0 1 0 0 1
151.07, 150.60, 151.07, 1 15 151 151. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 .,.,.,.,.,.,.,., 16 8 0 1 0 0 1
128.79, 127.86, 128.79, 1 12 128 128. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 .,.,.,.,.,.,.., 15 7 0 1 0 0 1
calculated for calculated c ca cal calc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 []:.,.. 7 9 0 1 0 0 1
6-(4-Chlorophenyl)-5-methyl-3-(4-(trifluoromethyl)benzyl)- 6-(4-Chlorophenyl)-5-methyl-3-(4-(trifluoromethyl)benzyl)- 6-(4-chlorophenyl)-5-methyl-3-(4-(trifluoromethyl)benzyl)- 6 6- 6-( 6-(4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 -(-)----(-())- 14 7 0 1 0 0 1
thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione (7e). thieno[2,3-d]pyrimidine-2,4(1h,3h)-dione t th thi thie BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 [,-]-,(,)-().(.,. 17 8 0 1 0 0 1
mmol) and mmol) m mm mmo mmol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 5 )-()(.,. 8 7 0 1 0 0 1
mmol) were mmol) m mm mmo mmol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 5 ) 1 8 0 1 0 0 1
7a, affording 7a, 7 7a 7a, 7a, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 ,(.,). 6 8 0 1 0 0 1
NMR (500 nmr N NM NMR NMR BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 5 (,-).(,),.(,., 14 8 0 1 0 0 1
2H), 7.56-7.44 2h), 2 2H 2H) 2H), BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 ),.-.(,),.(,),.(,).( 20 8 0 1 0 0 1
MHz, DMSO-d mhz, M MH MHz MHz, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 5 ,-).,.,.,.,.,.,., 17 8 0 1 0 0 1
131.1 (q, 131.1 1 13 131 131. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 .(,.),.,.,.,.,.,.(, 19 9 0 1 0 0 1
284.0 Hz), 284.0 2 28 284 284. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 .),.,.,.., 10 10 0 1 0 0 1
[M + [m [ [M [M [M BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 5 []:.,.. 7 4 0 1 0 0 1
3-Benzyl-6-(3,4-dichlorophenyl)-5-methylthieno[2,3-d]- 3-Benzyl-6-(3,4-dichlorophenyl)-5-methylthieno[2,3-d]- 3-benzyl-6-(3,4-dichlorophenyl)-5-methylthieno[2,3-d]- 3 3- 3-B 3-Be BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 ---(,-)--[,-]- 14 7 0 1 0 0 1
pyrimidine-2,4(1H,3H)-dione (7f). pyrimidine-2,4(1h,3h)-dione p py pyr pyri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 -,(,)-().(.,.) 14 8 0 1 0 0 1
isocyanate (0.2 isocyanate i is iso isoc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 5 (.,.) 5 8 0 1 0 0 1
to the to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 ,(.,) 5 9 0 1 0 0 1
white solid. white w wh whi whit BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 7 5 .(,-).(,),. 11 8 0 1 0 0 1
(dt, J (dt, ( (d (dt (dt, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 5 (,.,.,),.(,.,),.(,., 20 9 0 1 0 0 1
1H), 5.00 1h), 1 1H 1H) 1H), BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 ),.(,),.(,).(,-) 16 8 0 1 0 0 1
158.91, 150.35, 158.91, 1 15 158 158. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 .,.,.,.,.,.,.,., 16 8 0 1 0 0 1
129.23, 128.66, 129.23, 1 12 129 129. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 .,.,.,.,.,.,.,.,., 18 9 0 1 0 0 1
33.69. HRMS, 33.69. 3 33 33. 33.6 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 ..,[]:., 8 9 0 1 0 0 1
found 417.0225. found f fo fou foun BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 .. 2 2 0 1 0 0 1
3-Benzyl-6-(2,4-dichlorophenyl)-5-methylthieno[2,3-d]- 3-Benzyl-6-(2,4-dichlorophenyl)-5-methylthieno[2,3-d]- 3-benzyl-6-(2,4-dichlorophenyl)-5-methylthieno[2,3-d]- 3 3- 3-B 3-Be BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 ---(,-)--[,-]- 14 7 0 1 0 0 1
pyrimidine-2,4(1H,3H)-dione (7g). pyrimidine-2,4(1h,3h)-dione p py pyr pyri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 -,(,)-().(.,.) 14 8 0 1 0 0 1
isocyanate (0.2 isocyanate i is iso isoc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 5 (.,.) 5 8 0 1 0 0 1
to the to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 ,(,) 4 9 0 1 0 0 1
white solid. white w wh whi whit BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 7 5 .(,-).(,),.(, 13 8 0 1 0 0 1
J = j J J J J BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 5 .,),.-.(,),.-.(,),.-. 21 8 0 1 0 0 1
(m, 1H), (m, ( (m (m, (m, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 5 (,),.(,),.(,).(,- 17 7 0 1 0 0 1
d 6 d d d d d BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 7 5 ).,.,.,.,.,.,.,., 17 9 0 1 0 0 1
130.05, 129.79, 130.05, 1 13 130 130. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 .,.,.,.,.,.,.,.,., 18 9 0 1 0 0 1
14.68. HRMS, 14.68. 1 14 14. 14.6 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 ..,[]:., 8 9 0 1 0 0 1
found 417.0225. found f fo fou foun BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 .. 2 2 0 1 0 0 1
3-Benzyl-5-methyl-6-(3-(trifluoromethyl)phenyl)thieno[2,3-d]- 3-Benzyl-5-methyl-6-(3-(trifluoromethyl)phenyl)thieno[2,3-d]- 3-benzyl-5-methyl-6-(3-(trifluoromethyl)phenyl)thieno[2,3-d]- 3 3- 3-B 3-Be BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 -----(-())[,-]- 15 7 0 1 0 0 1
pyrimidine-2,4(1H,3H)-dione (7h). pyrimidine-2,4(1h,3h)-dione p py pyr pyri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 -,(,)-().(.,.) 14 7 0 1 0 0 1
benzyl isocyanate benzyl b be ben benz BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 5 (.,.) 5 7 0 1 0 0 1
procedure similar procedure p pr pro proc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 ,( 2 8 0 1 0 0 1
mg, yield mg, m mg mg, mg, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 5 ,).(,-) 7 8 0 1 0 0 1
12.46 (s, 12.46 1 12 12. 12.4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 .(,),.(,),.(,),.(,),.(, 23 8 0 1 0 0 1
2H), 2.45 2h), 2 2H 2H) 2H), BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 ),.(,).(,-).,., 15 8 0 1 0 0 1
150.2, 137.5, 150.2, 1 15 150 150. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 .,.,.,.,.,.(,.),.,., 20 9 0 1 0 0 1
128.4, 127.4, 128.4, 1 12 128 128. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 .,.,.,.(,.),.,.,.,., 20 9 0 1 0 0 1
14.1. HRMS, 14.1. 1 14 14. 14.1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 ..,[]:., 8 9 0 1 0 0 1
found 417.0879. found f fo fou foun BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 .. 2 2 0 1 0 0 1
6-(Benzo[d][1,3]dioxol-5-yl)-3-benzyl-5-methylthieno[2,3-d]- 6-(Benzo[d][1,3]dioxol-5-yl)-3-benzyl-5-methylthieno[2,3-d]- 6-(benzo[d][1,3]dioxol-5-yl)-3-benzyl-5-methylthieno[2,3-d]- 6 6- 6-( 6-(B BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 -([][,]--)----[,-]- 19 7 0 1 0 0 1
pyrimidine-2,4(1H,3H)-dione (7i). pyrimidine-2,4(1h,3h)-dione p py pyr pyri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 -,(,)-().(.,.) 14 8 0 1 0 0 1
isocyanate (0.2 isocyanate i is iso isoc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 5 (.,.) 5 8 0 1 0 0 1
to the to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 ,(,) 4 9 0 1 0 0 1
white solid. white w wh whi whit BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 7 5 .(,-).(,),. 11 8 0 1 0 0 1
(dd, J (dd, ( (d (dd (dd, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 5 (,.,.,),.(,.,.,),.(, 20 9 0 1 0 0 1
6.3 Hz, 6.3 6 6. 6.3 6.3 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 .,),.(,),.(,),.(,).( 20 8 0 1 0 0 1
MHz, DMSO-d mhz, M MH MHz MHz, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 5 ,-).,.,.,.,.,., 15 8 0 1 0 0 1
129.63, 128.80, 129.63, 1 12 129 129. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 .,.,.,.,.,.,.,., 16 8 0 1 0 0 1
109.95, 109.19, 109.95, 1 10 109 109. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 .,.,.,.,.., 11 7 0 1 0 0 1
C 21 c C C C C BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 5 []:.,.. 7 7 0 1 0 0 1
2-(Chloromethyl)-6-(4-chlorophenyl)-5-methylthieno[2,3-d]- 2-(Chloromethyl)-6-(4-chlorophenyl)-5-methylthieno[2,3-d]- 2-(chloromethyl)-6-(4-chlorophenyl)-5-methylthieno[2,3-d]- 2 2- 2-( 2-(C BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 -()--(-)--[,-]- 15 7 0 1 0 0 1
pyrimidin-4(1H)-one (8a). pyrimidin-4(1h)-one p py pyr pyri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 -()-().(.,.)- 13 7 0 1 0 0 1
chloroacetonitrile (0.1 chloroacetonitrile c ch chl chlo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 5 (.,.)(, 7 8 0 1 0 0 1
6 mL) 6 6 6 6 6 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 7 5 ),-(). 6 8 0 1 0 0 1
Subsequently, the subsequently, S Su Sub Subs BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 5 , 1 8 0 1 0 0 1
Journal of journal J Jo Jou Jour BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 11 no 0 10 0 1 0 0 0
pubs.acs.org/jmc pubs.acs.org/jmc pubs.acs.org/jmc p pu pub pubs BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 11 ../ 3 10 0 1 0 0 0
Article Article article A Ar Art Arti BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 11 no 0 4 0 1 0 0 0
https://doi.org/10.1021/acs.jmedchem.1c01598 https://doi.org/10.1021/acs.jmedchem.1c01598 https://doi.org/10.1021/acs.jmedchem.1c01598 h ht htt http BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 8 11 ://././.. 9 10 0 0 0 0 0
J. Med. j. J J. J. J. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 11 ...,,- 6 7 0 0 0 0 0
2073 2073 2073 2 20 207 2073 BLOCKSTART PAGEEND NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 8 11 no 0 10 0 0 0 0 0
precipitation formed. precipitation p pr pre prec BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 ., 2 8 0 1 0 0 1
reaction mixture reaction r re rea reac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 - 1 9 0 1 0 0 1
hexane. The hexane. h he hex hexa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 . 1 8 0 1 0 0 1
with DCM:MeOH with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 ::(/). 6 8 0 1 0 0 1
white solid. white w wh whi whit BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 8 0 ..(,-).(, 9 8 0 1 0 0 1
1H), 7.55 1h), 1 1H 1H) 1H), BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 ),.(,),.(,),.(,).(, 19 8 0 1 0 0 1
DMSO-d 6 dmso-d D DM DMS DMSO BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 -).,.,.,.,.,.,.,., 18 9 0 1 0 0 1
130.0, 129.1, 130.0, 1 13 130 130. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 .,.,.,.,.,.., 13 8 0 1 0 0 1
C 14 c C C C C BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 8 0 []:.,.. 7 8 0 1 0 0 1
2-Benzyl-6-(4-chlorophenyl)-5-methylthieno[2,3-d]pyrimidin- 2-Benzyl-6-(4-chlorophenyl)-5-methylthieno[2,3-d]pyrimidin- 2-benzyl-6-(4-chlorophenyl)-5-methylthieno[2,3-d]pyrimidin- 2 2- 2-B 2-Be BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 ---(-)--[,-]- 13 7 0 1 0 0 1
4(1H)-one (8b). 4(1h)-one 4 4( 4(1 4(1H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 ()-().(.,.)- 12 7 0 1 0 0 1
phenylacetonitrile (0.20 phenylacetonitrile p ph phe phen BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 (.,.) 5 9 0 1 0 0 1
synthesis of synthesis s sy syn synt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 (,). 4 9 0 1 0 0 1
(500 MHz, (500 ( (5 (50 (500 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 (,-).(,),.-.(,),.-.(, 21 8 0 1 0 0 1
4H), 7.3-7.2 4h), 4 4H 4H) 4H), BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 ),.-.(,),.(,),.(,).( 20 8 0 1 0 0 1
MHz, DMSO-d mhz, M MH MHz MHz, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 ,-).,.,.,.,.,.,., 17 9 0 1 0 0 1
130.9, 130.8, 130.9, 1 13 130 130. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 .,.,.,.,.,.,.,.,..,. 20 9 0 1 0 0 1
ppm. HRMS, ppm. p pp ppm ppm. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 .,[]:., 7 9 0 1 0 0 1
found 367.0665. found f fo fou foun BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 .. 2 2 0 1 0 0 1
2-Benzyl-6-(4-fluorophenyl)-5-methylthieno[2,3-d]pyrimidin- 2-Benzyl-6-(4-fluorophenyl)-5-methylthieno[2,3-d]pyrimidin- 2-benzyl-6-(4-fluorophenyl)-5-methylthieno[2,3-d]pyrimidin- 2 2- 2-B 2-Be BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 ---(-)--[,-]- 13 7 0 1 0 0 1
4(1H)-one (8c). 4(1h)-one 4 4( 4(1 4(1H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 ()-().(.,.)-(- 14 8 0 1 0 0 1
methoxyphenyl)acetonitrile (0.21 methoxyphenyl)acetonitrile m me met meth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 )(.,.) 6 8 0 1 0 0 1
procedure of procedure p pr pro proc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 (,) 3 9 0 1 0 0 1
solid. 1 solid. s so sol soli BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 .(,-).(,),.(, 13 9 0 1 0 0 1
8.7, 5.4 8.7, 8 8. 8.7 8.7, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 .,.,),.-.(,),.(,.,),.(, 23 9 0 1 0 0 1
2H), 2.49 2h), 2 2H 2H) 2H), BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 ),.(,).(,-).,. 14 8 0 1 0 0 1
(d, J (d, ( (d (d, (d, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 (,.),.,.,.,.,.,.,.,., 21 9 0 1 0 0 1
129.0, 127.4, 129.0, 1 12 129 129. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 .,.,.,.(,.),.,.., 17 9 0 1 0 0 1
for C for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 []:.,.. 7 8 0 1 0 0 1
6-(4-Chlorophenyl)-2-(3-methoxybenzyl)-5-methylthieno[2,3-d]- 6-(4-Chlorophenyl)-2-(3-methoxybenzyl)-5-methylthieno[2,3-d]- 6-(4-chlorophenyl)-2-(3-methoxybenzyl)-5-methylthieno[2,3-d]- 6 6- 6-( 6-(4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 -(-)--(-)--[,-]- 16 8 0 1 0 0 1
pyrimidin-4(1H)-one (8d). pyrimidin-4(1h)-one p py pyr pyri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 -()-().(.,)- 12 8 0 1 0 0 1
phenylacetonitrile (0.21 phenylacetonitrile p ph phe phen BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 (.,.) 5 9 0 1 0 0 1
synthesis of synthesis s sy syn synt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 (,). 4 9 0 1 0 0 1
(500 MHz, (500 ( (5 (50 (500 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 (,-).(,),.-.(,),.(, 19 8 0 1 0 0 1
7.8 Hz, 7.8 7 7. 7.8 7.8 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 .,),.-.(,),.(,.,),.(, 21 9 0 1 0 0 1
8.4, 2.7, 8.4, 8 8. 8.4 8.4, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 .,.,.,),.(,),.(,),.(,). 23 9 0 1 0 0 1
NMR (126 nmr N NM NMR NMR BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 (,-).,.,.,.,., 14 8 0 1 0 0 1
132.8, 131.7, 132.8, 1 13 132 132. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 .,.,.,.,.,.,.,.,.,., 20 9 0 1 0 0 1
121.0, 114.8, 121.0, 1 12 121 121. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 .,.,.,.,.,.., 13 8 0 1 0 0 1
C 21 c C C C C BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 8 0 []:.,.. 7 8 0 1 0 0 1
Synthesis of synthesis S Sy Syn Synt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 0 no 0 8 0 1 0 0 1
(ethyl 2-amino-4-phenylthiophene-3-carboxylate, (ethyl ( (e (et (eth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 (-----,). 9 9 0 1 0 0 1
mixture of mixture m mi mix mixt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 (,.) 4 8 0 1 0 0 1
(0.50 mL) (0.50 ( (0 (0. (0.5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 (.)., 5 9 0 1 0 0 1
cyanoacetate (0.60 cyanoacetate c cy cya cyan BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 (.,.)(., 8 8 0 1 0 0 1
mmol) were mmol) m mm mmo mmol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 ), 2 9 0 1 0 0 1
temperature for temperature t te tem temp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 ., 2 9 0 1 0 0 1
by TLC, by b by by by BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 , 1 8 0 1 0 0 1
CH 2 ch C CH CH CH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 ,. 2 6 0 1 0 0 1
Ethyl 2-Amino-4-(4-chlorophenyl)thiophene-3-carboxylate ethyl E Et Eth Ethy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 8 0 ---(-)-- 8 7 0 1 0 0 1
(10b). 10b (10b). ( (1 (10 (10b BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 (). 3 8 0 1 0 0 1
preparation of preparation p pr pre prep BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 -(-)--() 8 9 0 1 0 0 1
starting material. starting s st sta star BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 .() 3 8 0 1 0 0 1
product with product p pr pro prod BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 . 1 3 0 1 0 0 1
3-Benzyl-5-phenylthieno[2,3-d]pyrimidine-2,4(1H,3H)-dione 3-Benzyl-5-phenylthieno[2,3-d]pyrimidine-2,4(1H,3H)-dione 3-benzyl-5-phenylthieno[2,3-d]pyrimidine-2,4(1h,3h)-dione 3 3- 3-B 3-Be BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 ---[,-]-,(,)- 13 7 0 1 0 0 1
(11a). 11a (11a). ( (1 (11 (11a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 ().. 4 9 0 1 0 0 1
(500 MHz, (500 ( (5 (50 (500 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 (,-).(,),.(,.,),. 17 9 0 1 0 0 1
(q, J (q, ( (q (q, (q, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 (,.,.,),.(,.,),.(,., 20 9 0 1 0 0 1
1H), 7.04 1h), 1 1H 1H) 1H), BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 ),.(,),.(,).(,-) 16 8 0 1 0 0 1
158.14, 152.69, 158.14, 1 15 158 158. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 .,.,.,.,.,.,.,., 16 8 0 1 0 0 1
127.55, 127.47, 127.55, 1 12 127 127. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 .,.,.,.,.,.,.., 15 8 0 1 0 0 1
calculated for calculated c ca cal calc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 []:.,.. 7 9 0 1 0 0 1
3-Benzyl-5-(4-chlorophenyl)thieno[2,3-d]pyrimidine-2,4(1H,3H)- 3-Benzyl-5-(4-chlorophenyl)thieno[2,3-d]pyrimidine-2,4(1H,3H)- 3-benzyl-5-(4-chlorophenyl)thieno[2,3-d]pyrimidine-2,4(1h,3h)- 3 3- 3-B 3-Be BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 ---(-)[,-]-,(,)- 16 8 0 1 0 0 1
dione (11b). dione d di dio dion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 8 0 ().. 4 9 0 1 0 0 1
NMR (500 nmr N NM NMR NMR BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 (,-).(,),.(,., 14 8 0 1 0 0 1
2H), 7.42 2h), 2 2H 2H) 2H), BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 ),.(,.,),.-.(,),.(,),. 22 9 0 1 0 0 1
(s, 2H). (s, ( (s (s, (s, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 (,).(,-).,.,., 14 8 0 1 0 0 1
137.43, 137.39, 137.43, 1 13 137 137. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 .,.,.,.,.,.,.,., 16 8 0 1 0 0 1
126.94, 121.99, 126.94, 1 12 126 126. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 .,.,.,.., 9 10 0 1 0 0 1
[M + [m [ [M [M [M BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 []:.,.. 7 5 0 1 0 0 1
Preparation of preparation P Pr Pre Prep BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 7 . 1 7 0 1 0 0 1
procedures to procedures p pr pro proc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 no 0 8 0 1 0 0 1
our previous our o ou our our BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 . 1 9 0 1 0 0 1
(Invitrogen) were (invitrogen) ( (I (In (Inv BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 7 (). 3 9 0 1 0 0 1
into a into i in int into BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 (),- 4 9 0 1 0 0 1
performed in performed p pe per perf BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 .().- 5 8 0 1 0 0 1
produced overnight, produced p pr pro prod BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 , 1 8 0 1 0 0 1
sonicated. The sonicated. s so son soni BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 7 . 1 9 0 1 0 0 1
column (GE column c co col colu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 (). 3 8 0 1 0 0 1
containing MIF2 containing c co con cont BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 . 1 8 0 1 0 0 1
loaded on loaded l lo loa load BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 () 2 8 0 1 0 0 1
with a with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 no 0 8 0 1 0 0 1
phosphate buffer, phosphate p ph pho phos BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 ,.., 4 9 0 1 0 0 1
exclusion chromatography exclusion e ex exc excl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 () 2 9 0 1 0 0 1
in 20 in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 9 7 ,., 3 9 0 1 0 0 1
characteristic for characteristic c ch cha char BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 . 1 8 0 1 0 0 1
concentrated using concentrated c co con conc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 no 0 8 0 1 0 0 1
molecular-weight cutoff molecular-weight m mo mol mole BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 -( 2 8 0 1 0 0 1
GmbH). Purified gmbh). G Gm Gmb GmbH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 7 ).,- 4 8 0 1 0 0 1
nitrogen, and nitrogen, n ni nit nitr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 ,-. 3 9 0 1 0 0 1
was tested was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 - 1 9 0 1 0 0 1
phoresis (SDS-PAGE) phoresis p ph pho phor BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 7 (-). 4 6 0 1 0 0 1
Tautomerase Assay. tautomerase T Ta Tau Taut BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 7 . 1 8 0 1 0 0 1
kinetics were kinetics k ki kin kine BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 7 . 1 9 0 1 0 0 1
methods to methods m me met meth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 no 0 9 0 1 0 0 1
to study to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 .,() 4 8 0 1 0 0 1
demiwater was demiwater d de dem demi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 7 () 2 8 0 1 0 0 1
boric acid boric b bo bor bori BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 7 (,.), 5 9 0 1 0 0 1
μL of μl μ μL μL μL BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 7 . 1 9 0 1 0 0 1
homogenized and homogenized h ho hom homo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 7 . 1 8 0 1 0 0 1
Subsequently, 50 subsequently, S Su Sub Subs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 7 ,- 2 8 0 1 0 0 1
with 50 with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 () 2 9 0 1 0 0 1
buffer (50 buffer b bu buf buff BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 (,.). 5 9 0 1 0 0 1
over time over o ov ove over BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 . 1 9 0 1 0 0 1
activity in activity a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 no 0 9 0 1 0 0 1
100%. Noncatalyzed 100%. 1 10 100 100% BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 7 . 1 9 0 1 0 0 1
was set was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 . 1 9 0 1 0 0 1
calculate the calculate c ca cal calc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 . 1 9 0 1 0 0 1
the calculation. the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 . 1 2 0 1 0 0 1
Cell Culture. cell C Ce Cel Cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 7 . 1 9 0 1 0 0 1
A549 (ATCC-CCL-185), a549 A A5 A54 A549 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 7 (--),(--), 10 7 0 1 0 0 1
(ATCC-CRL-5803), and (atcc-crl-5803), ( (A (AT (ATC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 7 (--),(--)- 10 7 0 1 0 0 1
tured in tured t tu tur ture BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 7 -(#-) 5 8 0 1 0 0 1
10% (v/v) 10% 1 10 10% 10% BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 7 (/)()// 7 8 0 1 0 0 1
streptomycin (GibcoTM#10378016) streptomycin s st str stre BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 7 (#) 3 8 0 1 0 0 1
humidified air. humidified h hu hum humi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 . 1 2 0 1 0 0 1
Cell Proliferation cell C Ce Cel Cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 7 . 1 8 0 1 0 0 1
the CyQUANT the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 (, 2 9 0 1 0 0 1
#C35011) by #c35011) # #C #C3 #C35 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 7 #).- 4 9 0 1 0 0 1
plates at plates p pl pla plat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 / 1 9 0 1 0 0 1
concentrations of concentrations c co con conc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 (.-). 5 8 0 1 0 0 1
incubated with incubated i in inc incu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 7 () 2 9 0 1 0 0 1
5% CO 5% 5 5% 5% 5% BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 7 ./ 2 9 0 1 0 0 1
plate reader plate p pl pla plat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 (). 3 3 0 1 0 0 1
Clonogenic Assay. clonogenic C Cl Clo Clon BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 7 .-( 3 9 0 1 0 0 1
per well per p pe per per BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 ) 1 10 0 1 0 0 1
and incubated and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 . 1 9 0 1 0 0 1
cell culture cell c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 , 1 10 0 1 0 0 1
days. Subsequently, days. d da day days BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 ., 2 9 0 1 0 0 1
were washed were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 (/) 3 8 0 1 0 0 1
paraformaldehyde for paraformaldehyde p pa par para BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 7 . 1 9 0 1 0 0 1
the fixation the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 ,.(/) 5 9 0 1 0 0 1
violet in violet v vi vio viol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 9 7 ., 2 9 0 1 0 0 1
cancer cell cancer c ca can canc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 . 1 9 0 1 0 0 1
staining, 10% staining, s st sta stai BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 ,. 2 9 0 1 0 0 1
absorbance at absorbance a ab abs abso BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 7 no 0 9 0 1 0 0 1
relative cell relative r re rel rela BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 -. 2 8 0 1 0 0 1
Tumor Spheroid tumor T Tu Tum Tumo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 7 .(/) 4 7 0 1 0 0 1
seeded onto seeded s se see seed BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 7 -(). 4 9 0 1 0 0 1
After 2 after A Af Aft Afte BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 7 , 1 9 0 1 0 0 1
Journal of journal J Jo Jou Jour BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 11 no 0 10 0 1 0 0 0
pubs.acs.org/jmc pubs.acs.org/jmc pubs.acs.org/jmc p pu pub pubs BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 11 ../ 3 10 0 1 0 0 0
Article Article article A Ar Art Arti BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 11 no 0 4 0 1 0 0 0
https://doi.org/10.1021/acs.jmedchem.1c01598 https://doi.org/10.1021/acs.jmedchem.1c01598 https://doi.org/10.1021/acs.jmedchem.1c01598 h ht htt http BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 9 11 ://././.. 9 10 0 0 0 0 0
J. Med. j. J J. J. J. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 11 ...,,- 6 7 0 0 0 0 0
2074 2074 2074 2 20 207 2074 BLOCKSTART PAGEEND NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 9 11 no 0 10 0 0 0 0 0
treated with treated t tr tre trea BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 ., 2 9 0 0 0 0 1
and the and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 no 0 8 0 0 0 0 1
indicated days indicated i in ind indi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 -( 2 8 0 0 0 0 1
Eclipse Ti) eclipse E Ec Ecl Ecli BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 0 )-. 3 8 0 0 0 0 1
analyzed and analyzed a an ana anal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 . 1 5 0 0 0 0 1
ERK Phosphorylation erk E ER ERK ERK BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 . 1 8 0 0 0 0 1
well of well w we wel well BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 - 1 10 0 0 0 0 1
of RPMI-1640 of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 -.(/)(, 7 8 0 0 0 0 1
Badhoevedorp, The badhoevedorp, B Ba Bad Badh BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 ,),(/)/ 7 7 0 0 0 0 1
streptomycin solution streptomycin s st str stre BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 ()., 4 9 0 0 0 0 1
were stimulated were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 (/-) 4 8 0 0 0 0 1
mixture of mixture m mi mix mixt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 . 1 8 0 0 0 0 1
Subsequently, the subsequently, S Su Sub Subs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 0 , 1 8 0 0 0 0 1
RIPA buffer ripa R RI RIP RIPA BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 9 0 () 2 8 0 0 0 0 1
cocktail (Roche, cocktail c co coc cock BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 (,,). 5 8 0 0 0 0 1
protein concentration protein p pr pro prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 no 0 8 0 0 0 0 1
Kit (Pierce, kit K Ki Kit Kit BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 9 0 (,), 4 8 0 0 0 0 1
separated by separated s se sep sepa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 -(). 4 8 0 0 0 0 1
proteins in proteins p pr pro prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 ( 1 8 0 0 0 0 1
difluoride) (PVDF) difluoride) d di dif difl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 )().(/) 7 8 0 0 0 0 1
skimmed milk skimmed s sk ski skim BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 no 0 8 0 0 0 0 1
appropriate primary appropriate a ap app appr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 (,#,,:; 7 8 0 0 0 0 1
ERK, #9102, erk, E ER ERK ERK, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 ,#,,:;,#,, 10 8 0 0 0 0 1
1:10 000) 1:10 1 1: 1:1 1:10 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 :),- 4 8 0 0 0 0 1
conjugated secondary conjugated c co con conj BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 no 0 7 0 0 0 0 1
visualized with visualized v vi vis visu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 ()( 3 8 0 0 0 0 1
Healthcare)and quantified healthcare)and H He Hea Heal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 ). 2 8 0 0 0 0 1
Flow Cytometry. flow F Fl Flo Flow BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 0 ., 2 8 0 0 0 0 1
in six-well in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 9 0 -., 3 9 0 0 0 0 1
cells were cells c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 ., 2 9 0 0 0 0 1
cells were cells c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 () 2 7 0 0 0 0 1
trypsinization. After trypsinization. t tr try tryp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 ., 2 9 0 0 0 0 1
with a with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 /()(, 5 8 0 0 0 0 1
P4864) and p4864) P P4 P48 P486 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 ).(/)-(,) 9 8 0 0 0 0 1
room temperature. room r ro roo room BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 . 1 8 0 0 0 0 1
cytometer Coulter, cytometer c cy cyt cyto BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 ,,)- 4 6 0 0 0 0 1
ately. A ately. a at ate atel BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 .. 2 9 0 0 0 0 1
analyzed using analyzed a an ana anal BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 (,). 4 7 0 0 0 0 1
■ ASSOCIATED ■ ■ ■ ■ ■ BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 9 4 no 0 10 0 0 0 0 1
* sı * * * * * BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 9 5 * 1 10 0 0 0 0 1
The Supporting the T Th The The BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 5 no 0 10 0 0 0 0 1
https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c01598. https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c01598. https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c01598. h ht htt http BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 9 5 ://..//./... 12 9 0 0 0 0 1
Additional figures additional A Ad Add Addi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 5 ; 1 8 0 0 0 0 1
purity and purity p pu pur puri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 ; 1 9 0 0 0 0 1
activity inhibition activity a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 ; 1 9 0 0 0 0 1
details; and details; d de det deta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 ;(,, 4 8 0 0 0 0 1
HRMS) (PDF) hrms) H HR HRM HRMS BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 )() 3 2 0 0 0 0 1
Molecular formula molecular M Mo Mol Mole BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 5 () 2 5 0 0 0 0 1
■ AUTHOR ■ ■ ■ ■ ■ BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 10 5 no 0 10 0 0 0 0 1
Corresponding Author corresponding C Co Cor Corr BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 5 no 0 10 0 0 0 0 1
Frank J. frank F Fr Fra Fran BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 10 5 .-, 3 10 0 0 0 0 1
Groningen Research groningen G Gr Gro Gron BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 (), 3 9 0 0 0 0 1
University of university U Un Uni Univ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 5 ,, 2 8 0 0 0 0 1
Netherlands; orcid.org/0000-0001-7217-9300; netherlands; N Ne Net Neth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ;./---; 7 8 0 0 0 0 1
Phone: +31-5-3638030; phone: P Ph Pho Phon BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 5 :--;:..@.; 10 8 0 0 0 0 1
Fax: +31-5-3637953 fax: F Fa Fax Fax: BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 5 :-- 3 3 0 0 0 0 1
Authors Authors authors A Au Aut Auth BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 6 no 0 10 0 1 0 0 1
Zhangping Xiao zhangping Z Zh Zha Zhan BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 6 -, 2 9 0 1 0 0 1
Groningen Research groningen G Gr Gro Gron BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 6 (), 3 8 0 1 0 0 1
University of university U Un Uni Univ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 6 ,, 2 8 0 1 0 0 1
Netherlands; orcid.org/0000-0003-0557-9843 netherlands; N Ne Net Neth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 6 ;./--- 6 7 0 1 0 0 1
Angelina Osipyan angelina A An Ang Ange BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 10 6 -, 2 10 0 1 0 0 1
Groningen Research groningen G Gr Gro Gron BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 6 (), 3 8 0 1 0 0 1
University of university U Un Uni Univ BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 6 ,, 2 8 0 0 0 0 1
Netherlands Netherlands netherlands N Ne Net Neth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 6 no 0 2 0 0 0 0 1
Shanshan Song shanshan S Sh Sha Shan BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 6 -, 2 8 0 0 0 0 1
Groningen Research groningen G Gr Gro Gron BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 6 (), 3 8 0 0 0 0 1
University of university U Un Uni Univ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 6 ,, 2 8 0 0 0 0 1
Netherlands; Molecular netherlands; N Ne Net Neth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 6 ;, 2 9 0 0 0 0 1
Institute of institute I In Ins Inst BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 6 (),, 4 10 0 0 0 0 1
AV Groningen, av A AV AV AV BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 6 , 1 5 0 0 0 0 1
Deng Chen deng D De Den Deng BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 10 6 -, 2 8 0 0 0 0 1
Groningen Research groningen G Gr Gro Gron BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 6 (), 3 8 0 0 0 0 1
University of university U Un Uni Univ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 6 ,, 2 8 0 0 0 0 1
Netherlands Netherlands netherlands N Ne Net Neth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 6 no 0 2 0 0 0 0 1
Reinder A. reinder R Re Rei Rein BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 6 .-, 3 9 0 0 0 0 1
Groningen Research groningen G Gr Gro Gron BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 6 (), 3 8 0 0 0 0 1
University of university U Un Uni Univ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 6 ,, 2 8 0 0 0 0 1
Netherlands Netherlands netherlands N Ne Net Neth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 6 no 0 2 0 0 0 0 1
Ronald van ronald R Ro Ron Rona BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 10 6 -, 2 9 0 0 0 0 1
Groningen Research groningen G Gr Gro Gron BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 6 (), 3 8 0 0 0 0 1
University of university U Un Uni Univ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 6 ,, 2 8 0 0 0 0 1
Netherlands Netherlands netherlands N Ne Net Neth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 6 no 0 2 0 0 0 0 1
Petra E. petra P Pe Pet Petr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 10 6 .- 2 8 0 0 0 0 1
Biology, Groningen biology, B Bi Bio Biol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 6 ,(), 4 9 0 0 0 0 1
University of university U Un Uni Univ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 6 ,, 2 8 0 0 0 0 1
Netherlands Netherlands netherlands N Ne Net Neth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 6 no 0 2 0 0 0 0 1
Robbert H. robbert R Ro Rob Robb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 10 6 .-, 3 9 0 0 0 0 1
Groningen Research groningen G Gr Gro Gron BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 6 (), 3 8 0 0 0 0 1
University of university U Un Uni Univ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 6 ,, 2 8 0 0 0 0 1
Netherlands Netherlands netherlands N Ne Net Neth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 6 no 0 2 0 0 0 0 1
Wim J. wim W Wi Wim Wim BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 6 .-, 3 8 0 0 0 0 1
Groningen Research groningen G Gr Gro Gron BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 6 (), 3 8 0 0 0 0 1
University of university U Un Uni Univ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 6 ,, 2 8 0 0 0 0 1
Netherlands; orcid.org/0000-0002-5162-9947 netherlands; N Ne Net Neth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 6 ;./--- 6 7 0 0 0 0 1
Barbro N. barbro B Ba Bar Barb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 6 .-, 3 8 0 0 0 0 1
Research Institute research R Re Res Rese BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 10 6 (), 3 8 0 0 0 0 1
Groningen, 9713 groningen, G Gr Gro Gron BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 6 ,,; 3 9 0 0 0 0 1
Medical Center medical M Me Med Medi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 6 , 1 9 0 0 0 0 1
Asthma and asthma A As Ast Asth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 6 ,, 2 8 0 0 0 0 1
Groningen, The groningen, G Gr Gro Gron BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 6 , 1 4 0 0 0 0 1
Gerrit J. gerrit G Ge Ger Gerr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 10 6 .-, 3 9 0 0 0 0 1
Groningen Research groningen G Gr Gro Gron BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 6 (), 3 8 0 0 0 0 1
University of university U Un Uni Univ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 6 ,, 2 8 0 0 0 0 1
Netherlands; orcid.org/0000-0002-6917-6368 netherlands; N Ne Net Neth BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 6 ;./--- 6 7 0 0 0 0 1
Complete contact complete C Co Com Comp BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 10 : 1 9 0 0 0 0 1
https://pubs.acs.org/10.1021/acs.jmedchem.1c01598 https://pubs.acs.org/10.1021/acs.jmedchem.1c01598 https://pubs.acs.org/10.1021/acs.jmedchem.1c01598 h ht htt http BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 10 10 ://.././.. 10 10 0 0 0 0 1
Author Contributions author A Au Aut Auth BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 10 no 0 10 0 0 0 0 1
All authors all A Al All All BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 10 no 0 10 0 0 0 0 1
manuscript. manuscript. manuscript. m ma man manu BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 10 . 1 2 0 0 0 0 1
Funding Funding funding F Fu Fun Fund BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 10 no 0 10 0 0 0 0 1
Z.X. and z.x. Z Z. Z.X Z.X. BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 10 ....( 5 10 0 0 0 0 1
nos.: 201706010341 nos.: n no nos nos. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 10 .:..,..)... 11 9 0 0 0 0 1
was supported was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 10 - 1 8 0 0 0 0 1
Action (CoFund action A Ac Act Acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 10 ()... 5 10 0 0 0 0 1
Prof. Dr. prof. P Pr Pro Prof BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 10 .... 4 9 0 0 0 0 1
Groningen. Groningen. groningen. G Gr Gro Gron BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 10 . 1 1 0 0 0 0 1
Notes Notes notes N No Not Note BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 11 no 0 10 0 1 0 0 1
The authors the T Th The The BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 11 . 1 10 0 1 0 0 1
■ ACKNOWLEDGMENTS ■ ■ ■ ■ ■ BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 10 11 no 0 10 0 1 0 0 1
The authors the T Th The The BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 11 .. 2 10 0 1 0 0 1
Wang from wang W Wa Wan Wang BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 10 11 , 1 9 0 1 0 0 1
Journal of journal J Jo Jou Jour BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 11 no 0 10 0 1 0 0 0
pubs.acs.org/jmc pubs.acs.org/jmc pubs.acs.org/jmc p pu pub pubs BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 11 ../ 3 10 0 1 0 0 0
Article Article article A Ar Art Arti BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 11 no 0 4 0 1 0 0 0
https://doi.org/10.1021/acs.jmedchem.1c01598 https://doi.org/10.1021/acs.jmedchem.1c01598 https://doi.org/10.1021/acs.jmedchem.1c01598 h ht htt http BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 10 11 ://././.. 9 10 0 1 0 0 0
J. Med. j. J J. J. J. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 11 ...,,- 6 7 0 1 0 0 0
2075 2075 2075 2 20 207 2075 BLOCKSTART PAGEEND NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 10 11 no 0 10 0 1 0 0 0
Institute of institute I In Ins Inst BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 0 ,, 2 10 0 1 0 0 1
help on help h he hel help BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 . 1 5 0 1 0 0 1
■ ABBREVIATIONS ■ ■ ■ ■ ■ BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 10 0 no 0 10 0 1 0 0 1
4-CPP, 4-chlorophenylpyruvate; 4-cpp, 4 4- 4-C 4-CP BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 -,-;-,-- 8 9 0 1 0 0 1
uvate; 4-MPP, uvate; u uv uva uvat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 ;-,-;, 6 9 0 1 0 0 1
differentiation 74; differentiation d di dif diff BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 ;,;-,- 6 9 0 1 0 0 1
dopachrome tautomerase; dopachrome d do dop dopa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 ;,,-; 5 8 0 1 0 0 1
DMSO, dimethyl dmso, D DM DMS DMSO BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,;,---(-- 9 9 0 1 0 0 1
nopropyl) carbodiimide nopropyl) n no nop nopr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 );,- 4 8 0 1 0 0 1
amine tetraacetic amine a am ami amin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 ;,- 3 9 0 1 0 0 1
assay; FID, assay; a as ass assa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 ;,;, 4 8 0 1 0 0 1
hydroxybenzotriazole; HTS, hydroxybenzotriazole; h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 ;,-; 4 8 0 1 0 0 1
JAB1, c-Jun jab1, J JA JAB JAB1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 ,---;, 6 8 0 1 0 0 1
mitogen-activated protein mitogen-activated m mi mit mito BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 -;, 3 9 0 1 0 0 1
inhibitory factor; inhibitory i in inh inhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 ;,;,- 5 10 0 1 0 0 1
relationship relationship relationship r re rel rela BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 no 0 2 0 1 0 0 1
■ REFERENCES ■ ■ ■ ■ ■ BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 10 0 no 0 10 0 0 0 0 1
(1) Bray, (1) ( (1 (1) (1) BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 (),.;,.;,.;,..;,..; 19 10 0 0 0 0 1
Jemal, A. jemal, J Je Jem Jema BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,.: 3 8 0 0 0 0 1
incidence and incidence i in inc inci BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 . 1 9 0 0 0 0 1
Ca-Cancer J. ca-cancer C Ca Ca- Ca-C BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 -..,,-. 7 5 0 0 0 0 1
(2) Dagogo-Jack, (2) ( (2 (2) (2) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 ()-,.;,.. 9 7 0 0 0 0 1
resistance to resistance r re res resi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 .....,,-. 9 9 0 0 0 0 1
(3) Hahn, (3) ( (3 (3) (3) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 (),..;,..;,..;,.;,. 19 9 0 0 0 0 1
A.; Druker, a.; A A. A.; A.; BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 .;,..;,..;,.;,.;,..;,.; 23 9 0 0 0 0 1
Kuo, C. kuo, K Ku Kuo Kuo, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,..;,.;,..;,.;,.;,. 19 9 0 0 0 0 1
L.; Talamas, l.; L L. L.; L.; BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 .;,..;,.;,..;,..;,. 19 9 0 0 0 0 1
A.; Gerhard, a.; A A. A.; A.; BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 .;,..;.. 8 9 0 0 0 0 1
2021, 184, 2021, 2 20 202 2021 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 0 ,,-. 4 2 0 0 0 0 1
(4) Penticuff, (4) ( (4 (4) (4) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 (),..;,..;,..;,..; 18 9 0 0 0 0 1
Taylor, J. taylor, T Ta Tay Tayl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,..: 4 9 0 0 0 0 1
roles and roles r ro rol role BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 ....,,-. 8 9 0 0 0 0 1
(5) Soumoy, (5) ( (5 (5) (5) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 (),.;,.;,.;,.;,. 16 9 0 0 0 0 1
of macrophage of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 (). 3 8 0 0 0 0 1
Cancers 2019, cancers C Ca Can Canc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 0 ,,. 3 3 0 0 0 0 1
(6) Cavalli, (6) ( (6 (6) (6) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 (),.;,.;,..;,.;,.; 18 9 0 0 0 0 1
Mangano, K.; mangano, M Ma Man Mang BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,.;,.;,.;,.. 12 9 0 0 0 0 1
of the of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 no 0 9 0 0 0 0 1
neuroblastoma. Pathogenic neuroblastoma. n ne neu neur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 .? 2 9 0 0 0 0 1
Molecules 2020, molecules M Mo Mol Mole BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 0 ,,. 3 3 0 0 0 0 1
(7) Coleman, (7) ( (7 (7) (7) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 (),..;,..;,.;,.-.;, 19 8 0 0 0 0 1
R.; Xin, r.; R R. R.; R.; BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 .;,.;,..- 9 9 0 0 0 0 1
lung carcinoma lung l lu lun lung BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 no 0 8 0 0 0 0 1
inhibitory factor inhibitory i in inh inhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 ,-.. 4 8 0 0 0 0 1
Immunol. 2008, immunol. I Im Imm Immu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 .,,-. 5 4 0 0 0 0 1
(8) Charan, (8) ( (8 (8) (8) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 (),.;,.;,.;,.;,.;, 18 9 0 0 0 0 1
K.; Misri, k.; K K. K.; K.; BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 .;,.;,..;,..;,.. 16 9 0 0 0 0 1
migration inhibitory migration m mi mig migr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 no 0 9 0 0 0 0 1
against triple-negative against a ag aga agai BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 -..,,. 6 9 0 0 0 0 1
(9) Zhang, (9) ( (9 (9) (9) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 (),.;,.;,.. 11 8 0 0 0 0 1
growth, metastasis growth, g gr gro grow BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 ,- 2 8 0 0 0 0 1
reduction in reduction r re red redu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 ..,, 4 8 0 0 0 0 1
463-474. 463-474. 463-474. 4 46 463 463- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 -. 2 1 0 0 0 0 1
(10) Oliveira, (10) ( (1 (10 (10) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 (),..;,..;,..;,.; 17 9 0 0 0 0 1
Geng, X. geng, G Ge Gen Geng BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,..;,.;,..;,.. 14 8 0 0 0 0 1
migration inhibitory migration m mi mig migr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 / 1 8 0 0 0 0 1
prognostic factor prognostic p pr pro prog BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 .,,. 4 9 0 0 0 0 1
(11) Leng, (11) ( (1 (11 (11) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 (),.;,..;,.;,.;,.;,.; 21 9 0 0 0 0 1
Delohery, T.; delohery, D De Del Delo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,.;,.;,..;,. 12 8 0 0 0 0 1
transduction initiated transduction t tr tra tran BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 ....,, 6 9 0 0 0 0 1
1467-1476. 1467-1476. 1467-1476. 1 14 146 1467 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 0 -. 2 1 0 0 0 0 1
(12) Shi, (12) ( (1 (12 (12) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 (),.;,.;,.;,.;,.;,.; 20 8 0 0 0 0 1
McDonald, C.; mcdonald, M Mc McD McDo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,.;,.;,..;,.;,.; 16 8 0 0 0 0 1
Knudson, W.; knudson, K Kn Knu Knud BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,.;,. 5 8 0 0 0 0 1
macrophage migration macrophage m ma mac macr BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 -. 2 8 0 1 0 0 1
Immunity 2006, immunity I Im Imm Immu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 5 ,,-. 4 3 0 1 0 0 1
(13) Jäger, (13) ( (1 (13 (13) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 (),.;,.;,.;,.;,.; 17 9 0 1 0 0 1
Barbosa, P. barbosa, B Ba Bar Barb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,..;,.;,./ 10 9 0 1 0 0 1
tumor growth tumor t tu tum tumo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 -- 2 8 0 1 0 0 1
cell lung cell c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 ..,,.. 6 7 0 1 0 0 1
(14) Mahalingam, (14) ( (1 (14 (14) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 (),.;,.;,.;,.;,.; 17 9 0 1 0 0 1
Ramanathan, R.; ramanathan, R Ra Ram Rama BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,.;,.;,.;,.;,.;, 16 9 0 1 0 0 1
D.; Kerschbaumer, d.; D D. D.; D.; BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 .;,.;,.;,.;,.;, 15 9 0 1 0 0 1
K.; Wertheim, k.; K K. K.; K.; BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 .;,.;,.;,.;,.;,.; 17 9 0 1 0 0 1
Tsimberidou, A. tsimberidou, T Ts Tsi Tsim BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,.,- 4 8 0 1 0 0 1
oxidized macrophage oxidized o ox oxi oxid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 (), 3 8 0 1 0 0 1
alone or alone a al alo alon BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 -/(-/) 6 9 0 1 0 0 1
panitumumab, in panitumumab, p pa pan pani BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 ,(). 4 9 0 1 0 0 1
Ann. Oncol. ann. A An Ann Ann. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ..,,. 5 3 0 1 0 0 1
(15) Xiao, (15) ( (1 (15 (15) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 (),.;,.;,.;,.; 14 8 0 1 0 0 1
Wouden, P. wouden, W Wo Wou Woud BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,..;,.;,..;,...; 16 8 0 1 0 0 1
Melgert, B. melgert, M Me Mel Melg BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,..;,..;,..;,..- 16 8 0 1 0 0 1
Hydroxycoumarins are hydroxycoumarins H Hy Hyd Hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 -- 2 8 0 1 0 0 1
petitive binding petitive p pe pet peti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 .. 2 9 0 1 0 0 1
Med. Chem. med. M Me Med Med. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ..,,-. 6 4 0 1 0 0 1
(16) Illescas, (16) ( (1 (16 (16) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 (),.;-,.;,..;, 14 9 0 1 0 0 1
T.; Rodriguez-Sosa, t.; T T. T.; T.; BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 .;-,. 5 7 0 1 0 0 1
migration inhibitory migration m mi mig migr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 ():- 4 9 0 1 0 0 1
(DDT) is (ddt) ( (D (DD (DDT BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ()().,,. 8 9 0 1 0 0 1
(17) Merk, (17) ( (1 (17 (17) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 (),.;,.;,.;,.;,.;,.; 20 9 0 1 0 0 1
Fan, J.; fan, F Fa Fan Fan, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 5 ,.;,.;,.;,.;,.;,.; 18 9 0 1 0 0 1
Lolis, E.; lolis, L Lo Lol Loli BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,.;,.;,.;,.- 12 7 0 1 0 0 1
tautomerase (DDT) tautomerase t ta tau taut BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 () 2 8 0 1 0 0 1
homolog of homolog h ho hom homo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 ()... 5 9 0 1 0 0 1
Acad. Sci. acad. A Ac Aca Acad BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 .....,,-. 9 5 0 1 0 0 1
(18) Sugimoto, (18) ( (1 (18 (18) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 (),.;,.;,..;. 13 8 0 1 0 0 1
structure of structure s st str stru BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 -, 2 8 0 1 0 0 1
macrophage migration macrophage m ma mac macr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 ,.. 3 8 0 1 0 0 1
Biochemistry 1999, biochemistry B Bi Bio Bioc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 5 ,,-. 4 4 0 1 0 0 1
(19) Rajasekaran, (19) ( (1 (19 (19) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 (),.;,.;,.;,.;,.; 17 9 0 1 0 0 1
Lolis, E. lolis, L Lo Lol Loli BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,..- 4 9 0 1 0 0 1
a single a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 10 5 . 1 9 0 1 0 0 1
J. 2014, j. J J. J. J. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 .,,-. 5 3 0 1 0 0 1
(20) Bernhagen, (20) ( (2 (20 (20) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 (),.;,.;,.;,..;,.; 18 9 0 1 0 0 1
Koenen, R. koenen, K Ko Koe Koen BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,..;,.;,.;,.;,.; 16 8 0 1 0 0 1
Kooistra, T.; kooistra, K Ko Koo Kooi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,.;-,.;,.;,.;, 14 9 0 1 0 0 1
S. R.; s. S S. S. S. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ..;,.;,..;,. 12 9 0 1 0 0 1
of CXC of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 no 0 8 0 1 0 0 1
recruitment. Nat. recruitment. r re rec recr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 ...,,-. 7 5 0 1 0 0 1
(21) Weber, (21) ( (2 (21 (21) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 (),.;,.;,.;,.;,..; 18 9 0 1 0 0 1
Kapurniotu, A.; kapurniotu, K Ka Kap Kapu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,.;,.;,. 8 9 0 1 0 0 1
MIF functions mif M MI MIF MIF BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 - 1 8 0 1 0 0 1
leukocyte recruitment. leukocyte l le leu leuk BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 ........,,- 11 9 0 1 0 0 1
16283. 16283. 16283. 1 16 162 1628 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 5 . 1 0 0 1 0 0 1
(22) Pantouris, (22) ( (2 (22 (22) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 (),.;,..;,.;,.;,..; 19 9 0 1 0 0 1
Rosenberg, E. rosenberg, R Ro Ros Rose BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,..;,.;,.;,.. 13 9 0 1 0 0 1
MIF structural mif M MI MIF MIF BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 . 1 9 0 1 0 0 1
Chem. Biol. chem. C Ch Che Chem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ..,,-. 6 4 0 1 0 0 1
(23) Pantouris, (23) ( (2 (23 (23) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 (),.;,.;,.;,.;,.; 17 8 0 1 0 0 1
Batista, V. batista, B Ba Bat Bati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,..;,..;,.. 11 9 0 1 0 0 1
activity by activity a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 .. 2 10 0 1 0 0 1
Biol. 2020, biol. B Bi Bio Biol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 .,,-. 5 3 0 1 0 0 1
(24) Bloom, (24) ( (2 (24 (24) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 (),.;,.;-,.,: 13 9 0 1 0 0 1
review of review r re rev revi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 ,, 2 9 0 1 0 0 1
development. Expert development. d de dev deve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 ...,,-. 7 8 0 1 0 0 1
(25) Al-Abed, (25) ( (2 (25 (25) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 ()-,.;,.:- 10 9 0 1 0 0 1
proof-of-concept therapeutic. proof-of-concept p pr pro proo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 --...,,-. 9 8 0 1 0 0 1
(26) Meyer-Siegler, (26) ( (2 (26 (26) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 ()-,..;,..;,.;,.; 17 9 0 1 0 0 1
Vera, P. vera, V Ve Ver Vera BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,.. 3 9 0 1 0 0 1
receptor (CD74) receptor r re rec rece BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 ()- 3 8 0 1 0 0 1
cancer cells. cancer c ca can canc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 ...,,-. 7 6 0 1 0 0 1
(27) Dziedzic, (27) ( (2 (27 (27) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 (),.;,..;,..;,..; 17 9 0 1 0 0 1
Danford, N. danford, D Da Dan Danf BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,..;,...;,..,, 14 9 0 1 0 0 1
Journal of journal J Jo Jou Jour BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 11 no 0 10 0 1 0 0 0
pubs.acs.org/jmc pubs.acs.org/jmc pubs.acs.org/jmc p pu pub pubs BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 11 ../ 3 10 0 1 0 0 0
Article Article article A Ar Art Arti BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 11 no 0 4 0 1 0 0 0
https://doi.org/10.1021/acs.jmedchem.1c01598 https://doi.org/10.1021/acs.jmedchem.1c01598 https://doi.org/10.1021/acs.jmedchem.1c01598 h ht htt http BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 11 11 ://././.. 9 10 0 0 0 0 0
J. Med. j. J J. J. J. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 11 ...,,- 6 7 0 0 0 0 0
2076 2076 2076 2 20 207 2076 BLOCKSTART PAGEEND NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 11 11 no 0 10 0 0 0 0 0
and protein and a an and and BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 no 0 9 1 0 0 0 1
inhibitors of inhibitors i in inh inhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 .... 4 9 1 0 0 0 1
Soc. 2015, soc. S So Soc Soc. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 .,,-. 5 3 1 0 0 0 1
(28) Trivedi-Parmar, (28) ( (2 (28 (28) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 ()-,.;,..;,..;, 15 9 1 0 0 0 1
S. G.; s. S S. S. S. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 ..;,.. 6 9 1 0 0 0 1
to yield to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 . 1 9 1 0 0 0 1
ChemMedChem 2018, chemmedchem C Ch Che Chem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 ,,-. 4 4 1 0 0 0 1
(29) Xiao, (29) ( (2 (29 (29) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 (),.;,.;,.;,.;,..;, 19 9 1 0 0 0 1
R. H.; r. R R. R. R. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 ..;,..;,..;,..;,.. 18 9 1 0 0 0 1
Proteolysis targeting proteolysis P Pr Pro Prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 () 2 8 1 0 0 0 1
inhibitory factor inhibitory i in inh inhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 ()- 3 9 1 0 0 0 1
cells. Angew. cells. c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 ...,..,,-. 10 7 1 0 0 0 1
(30) Tilstam, (30) ( (3 (30 (30) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 (),..;,.;,.;,.; 15 8 1 0 0 0 1
Mahboubi, K.; mahboubi, M Ma Mah Mahb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 ,.;,.;,.;,.;,.;,. 17 9 1 0 0 0 1
selective small-molecule selective s se sel sele BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 - 1 9 1 0 0 0 1
factor-2 (MIF-2), factor-2 f fa fac fact BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 -(-),,- 7 8 1 0 0 0 1
2 biological 2 2 2 2 2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 11 0 ....,,-. 8 8 1 0 0 0 1
(31) Cho, (31) ( (3 (31 (31) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 (),.;,..;,..;,.;,.; 19 8 1 0 0 0 1
Hodsdon, M. hodsdon, H Ho Hod Hods BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 ,..;,.;,.;,.;,.; 16 8 1 0 0 0 1
Johnson, K.; johnson, J Jo Joh John BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 ,.;,.. 6 9 1 0 0 0 1
inhibitory factor inhibitory i in inh inhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 ........ 8 9 1 0 0 0 1
2010, 107, 2010, 2 20 201 2010 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 11 0 ,,-. 4 3 1 0 0 0 1
(32) Pantouris, (32) ( (3 (32 (32) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 (),.;,.;,.. 11 10 1 0 0 0 1
C-terminal region c-terminal C C- C-t C-te BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 -- 2 8 1 0 0 0 1
associated with associated a as ass asso BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 . 1 9 1 0 0 0 1
Biochemistry 2018, biochemistry B Bi Bio Bioc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 0 ,,-. 4 4 1 0 0 0 1
(33) Ouertatani-Sakouhi, (33) ( (3 (33 (33) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 ()-,.;,.;-,.;,..; 17 8 1 0 0 0 1
Glicksman, M. glicksman, G Gl Gli Glic BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 ,..;,.-- 8 8 1 0 0 0 1
screening assay screening s sc scr scre BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 no 0 8 1 0 0 0 1
inhibitory factor inhibitory i in inh inhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 ...,,-. 7 9 1 0 0 0 1
(34) Rosengren, (34) ( (3 (34 (34) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 (),.;,.;,.;,.;,.; 17 9 1 0 0 0 1
Björk, P.; björk, B Bj Bjö Björ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 ,.;,.;,. 8 8 1 0 0 0 1
inhibitory factor inhibitory i in inh inhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 .. 2 8 1 0 0 0 1
1997, 417, 1997, 1 19 199 1997 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 11 0 ,,-. 4 2 1 0 0 0 1
(35) Xiao, (35) ( (3 (35 (35) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 (),.;,.;,.;,.;,.; 17 8 1 0 0 0 1
Merkerk, R.; merkerk, M Me Mer Merk BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 ,.;,..;,..- 11 8 1 0 0 0 1
relationships for relationships r re rel rela BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 --- 3 9 1 0 0 0 1
phage migration phage p ph pha phag BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 ()....., 8 8 1 0 0 0 1
186, 111849-111862. 186, 1 18 186 186, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 ,-. 3 2 1 0 0 0 1
(36) Zhang, (36) ( (3 (36 (36) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 (),.-.;,...;,.. 15 8 1 0 0 0 1
statistical parameter statistical s st sta stat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 no 0 9 1 0 0 0 1
throughput screening throughput t th thr thro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 ...,,-. 7 8 1 0 0 0 1
(37) Lubetsky, (37) ( (3 (37 (37) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 (),..;,.;,.;,.;,.- 18 9 1 0 0 0 1
1 of 1 1 1 1 1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 11 0 no 0 9 1 0 0 0 1
base in base b ba bas base BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 ., 2 9 1 0 0 0 1
38, 7346-7354. 38, 3 38 38, 38, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 ,-. 3 2 1 0 0 0 1
(38) Ishikawa, (38) ( (3 (38 (38) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 (),.;,. 7 7 1 0 0 0 1
solubility in solubility s so sol solu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 no 0 9 1 0 0 0 1
of molecular of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 ....,,- 7 8 1 0 0 0 1
1554. 1554. 1554. 1 15 155 1554 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 11 0 . 1 0 1 0 0 0 1
(39) Feng, (39) ( (3 (39 (39) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 (),.;,..;,.;,..;, 17 8 1 0 0 0 1
D.; Huang, d.; D D. D.; D.; BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 .;,.;,..;,..;,.. 16 8 1 0 0 0 1
of new of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 ,----- 6 9 1 0 0 0 1
sulfanylenebenzo[d][1,3,2]oxazaphospholes with sulfanylenebenzo[d][1,3,2]oxazaphospholes s su sul sulf BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 [][,,]- 7 8 1 0 0 0 1
ferative activity. ferative f fe fer fera BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 ....,,-. 8 7 1 0 0 0 1
(40) Guo, (40) ( (4 (40 (40) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 (),.;,.;,.;,.;,.;,.;,.; 23 9 1 0 0 0 1
Lin, L.; lin, L Li Lin Lin, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 ,.;,.;,.-- 10 8 1 0 0 0 1
expressed in expressed e ex exp expr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 no 0 9 1 0 0 0 1
with macrophage with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 no 0 8 1 0 0 0 1
growth. Int. growth. g gr gro grow BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 ...,,-. 7 6 1 0 0 0 1
(41) Pasupuleti, (41) ( (4 (41 (41) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 (),.;,.;,.;,..;,.; 18 8 1 0 0 0 1
Magi-Galuzzi, C.; magi-galuzzi, M Ma Mag Magi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 -,.;,..- 8 7 1 0 0 0 1
tautomerase, a tautomerase, t ta tau taut BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 ,-, 3 8 1 0 0 0 1
with macrophage with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 .. 2 9 1 0 0 0 1
Biol. Chem. biol. B Bi Bio Biol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 ..,,-. 6 4 1 0 0 0 1
(42) Trivedi-Parmar, (42) ( (4 (42 (42) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 ()-,..;,.. 10 9 1 0 0 0 1
for small for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 no 0 8 1 0 0 0 1
factor. J. factor. f fa fac fact BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 ....,,-. 8 5 1 0 0 0 1
(43) Vinci, (43) ( (4 (43 (43) BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 (),.;,.;,.;,.;, 15 9 1 0 0 0 1
M.; Court, m.; M M. M.; M.; BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 .;,.;,.;,.;,.;,.. 17 9 1 0 0 0 1
Advances in advances A Ad Adv Adva BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 6 - 1 9 1 0 0 0 1
spheroid-based functional spheroid-based s sp sph sphe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 6 - 1 8 1 0 0 0 1
evaluation. BMC evaluation. e ev eva eval BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 ..,,.. 6 5 1 0 0 0 1
(44) Kobold, (44) ( (4 (44 (44) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 (),.;,.;,.;,.;,.;, 18 9 1 0 0 0 1
S. The s. S S. S. S. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 .()-- 5 8 1 0 0 0 1
dopachrome tautomerase dopachrome d do dop dopa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 6 no 0 8 1 0 0 0 1
melanoma model. melanoma m me mel mela BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 6 .,,-. 5 6 1 0 0 0 1
(45) Williams, (45) ( (4 (45 (45) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 (),..;,.... 11 10 1 0 0 0 1
2012, 226, 2012, 2 20 201 2012 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 11 6 ,,-. 4 2 1 0 0 0 1
(46) Song, (46) ( (4 (46 (46) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 (),.;,.;,.;,.;,..; 18 9 1 0 0 0 1
Gosens, R.; gosens, G Go Gos Gose BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 ,.;,.;,.-.;,..;,..; 19 9 1 0 0 0 1
Poelarends, G. poelarends, P Po Poe Poel BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 ,..;,..- 8 8 1 0 0 0 1
contributes to contributes c co con cont BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 no 0 9 1 0 0 0 1
3-dependent Akt 3-dependent 3 3- 3-d 3-de BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 -.,,.. 6 8 1 0 0 0 1
(47) Zhang, (47) ( (4 (47 (47) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 (),.;,.;,.;,.;,.;,.;,. 22 9 1 0 0 0 1
Bio-inspired enantioselective bio-inspired B Bi Bio Bio- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 - 1 8 1 0 0 0 1
available cyclodextrin. available a av ava avai BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 ..,,-. 6 7 1 0 0 0 1
(48) Eleftheriadis, (48) ( (4 (48 (48) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 (),.;,.;,...;,.; 16 9 1 0 0 0 1
Neochoritis, C. neochoritis, N Ne Neo Neoc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 ,..;,.;,.;,.. 13 9 1 0 0 0 1
novel thiophene novel n no nov nove BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 --- 3 8 1 0 0 0 1
inflammatory and inflammatory i in inf infl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 6 ..... 5 8 1 0 0 0 1
2016, 122, 2016, 2 20 201 2016 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 11 6 ,,-. 4 2 1 0 0 0 1
(49) Sasaki, (49) ( (4 (49 (49) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 (),.;,.;,.;,.;,.;,.; 20 9 1 0 0 0 1
Furuya, S.; furuya, F Fu Fur Furu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 ,.;,.[,-]-,- 12 9 1 0 0 0 1
dione bearing dione d di dio dion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 11 6 --: 3 9 1 0 0 0 1
highly potent highly h hi hig high BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 - 1 9 1 0 0 0 1
human luteinizing human h hu hum huma BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 -... 4 8 1 0 0 0 1
Chem. 2003, chem. C Ch Che Chem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 .,,-. 5 3 1 0 0 0 1
(50) Fyfe, (50) ( (5 (50 (50) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 (),..;,.;,..;,.;,..; 20 9 1 0 0 0 1
Katrich, V.; katrich, K Ka Kat Katr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 ,.;,..;,..;,.[,- 16 9 1 0 0 0 1
d]pyrimidine scaffold d]pyrimidine d d] d]p d]py BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 6 ] 1 9 1 0 0 0 1
dopamine D2 dopamine d do dop dopa BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 6 ....,,-. 8 7 1 0 0 0 1
Journal of journal J Jo Jou Jour BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 10 no 0 10 0 1 0 0 0
pubs.acs.org/jmc pubs.acs.org/jmc pubs.acs.org/jmc p pu pub pubs BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 10 ../ 3 10 0 1 0 0 0
Article Article article A Ar Art Arti BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 10 no 0 4 0 1 0 0 0
https://doi.org/10.1021/acs.jmedchem.1c01598 https://doi.org/10.1021/acs.jmedchem.1c01598 https://doi.org/10.1021/acs.jmedchem.1c01598 h ht htt http BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 11 10 ://././.. 9 10 1 1 0 0 0
J. Med. j. J J. J. J. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 10 ...,,- 6 7 1 1 0 0 0
2077 2077 2077 2 20 207 2077 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 11 10 no 0 10 1 1 0 0 0
Recommended by recommended R Re Rec Reco BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 10 no 0 10 1 0 0 0 1
Discovery of discovery D Di Dis Disc BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 10 ,,, 3 9 1 0 0 0 1
Inhibitor Targeting inhibitor I In Inh Inhi BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 10 no 0 10 1 0 0 0 1
Xinnan Li, xinnan X Xi Xin Xinn BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 10 ,,. 3 10 1 0 0 0 1
MARCH 30, march M MA MAR MARC BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 1 1 0 0 1 0 0 11 10 , 1 10 1 0 0 0 1
JOURNAL OF journal J JO JOU JOUR BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 11 10 no 0 10 1 0 0 0 1
READ READ read R RE REA READ BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 1 1 0 0 0 0 0 11 11 no 0 10 1 0 0 0 1
Exploration of exploration E Ex Exp Expl BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 11 () 2 9 1 0 0 0 1
(HDAC) Bispecific (hdac) ( (H (HD (HDA BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 11 () 2 8 1 0 0 0 1
Fedratinib for fedratinib F Fe Fed Fedr BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 11 ... 3 10 1 0 0 0 1
Qianqian Qiu, qianqian Q Qi Qia Qian BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 11 ,,. 3 10 1 0 0 0 1
APRIL 14, april A AP APR APRI BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 1 0 0 0 1 0 0 11 11 , 1 10 1 0 0 0 1
JOURNAL OF journal J JO JOU JOUR BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 11 11 no 0 10 1 0 0 0 1
READ READ read R RE REA READ BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 1 1 0 0 0 0 0 11 11 no 0 10 1 0 0 0 1
Discovery of discovery D Di Dis Disc BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 11 --- 3 10 1 0 0 0 1
Based Immunotherapy based B Ba Bas Base BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 11 no 0 3 1 0 0 0 1
Ming-Shu Wang, ming-shu M Mi Min Ming BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 11 -,-,. 5 10 1 0 0 0 1
DECEMBER 21, december D DE DEC DECE BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 0 0 0 1 0 0 11 11 , 1 10 1 0 0 0 1
JOURNAL OF journal J JO JOU JOUR BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 11 11 no 0 10 1 0 0 0 1
READ READ read R RE REA READ BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 1 1 0 0 0 0 0 11 11 no 0 10 1 0 0 0 1
Discovery of discovery D Di Dis Disc BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 11 -- 2 9 1 1 0 0 1
Inducible T-Cell inducible I In Ind Indu BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 11 - 1 10 1 1 0 0 1
Danli Zhou, danli D Da Dan Danl BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 11 ,,. 3 10 1 1 0 0 1
MARCH 23, march M MA MAR MARC BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 1 1 0 0 1 0 0 11 11 , 1 10 1 1 0 0 1
JOURNAL OF journal J JO JOU JOUR BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 11 11 no 0 10 1 1 0 0 1
READ READ read R RE REA READ BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 1 1 0 0 0 0 0 11 11 no 0 10 1 1 0 0 1
Get More get G Ge Get Get BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 11 no 0 10 1 1 0 0 1

